US20200359633A1 - Antimicrobial/antiviral composition - Google Patents
Antimicrobial/antiviral composition Download PDFInfo
- Publication number
- US20200359633A1 US20200359633A1 US16/638,857 US201816638857A US2020359633A1 US 20200359633 A1 US20200359633 A1 US 20200359633A1 US 201816638857 A US201816638857 A US 201816638857A US 2020359633 A1 US2020359633 A1 US 2020359633A1
- Authority
- US
- United States
- Prior art keywords
- antimicrobial
- antiviral
- resin
- coating
- copper
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 278
- 230000000840 anti-viral effect Effects 0.000 title claims abstract description 247
- 239000000203 mixture Substances 0.000 title claims abstract description 104
- 229920005989 resin Polymers 0.000 claims abstract description 226
- 239000011347 resin Substances 0.000 claims abstract description 226
- 239000004599 antimicrobial Substances 0.000 claims abstract description 93
- 239000005749 Copper compound Substances 0.000 claims abstract description 64
- 150000001880 copper compounds Chemical class 0.000 claims abstract description 64
- 239000011859 microparticle Substances 0.000 claims abstract description 60
- 150000002433 hydrophilic molecules Chemical class 0.000 claims abstract description 55
- 239000002270 dispersing agent Substances 0.000 claims abstract description 38
- 239000003443 antiviral agent Substances 0.000 claims abstract description 36
- 238000000576 coating method Methods 0.000 claims description 118
- 239000011248 coating agent Substances 0.000 claims description 116
- 239000000835 fiber Substances 0.000 claims description 71
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 claims description 61
- 238000000034 method Methods 0.000 claims description 34
- 238000002156 mixing Methods 0.000 claims description 24
- 150000002484 inorganic compounds Chemical group 0.000 claims description 22
- 229910010272 inorganic material Inorganic materials 0.000 claims description 22
- BERDEBHAJNAUOM-UHFFFAOYSA-N copper(I) oxide Inorganic materials [Cu]O[Cu] BERDEBHAJNAUOM-UHFFFAOYSA-N 0.000 claims description 12
- KRFJLUBVMFXRPN-UHFFFAOYSA-N cuprous oxide Chemical compound [O-2].[Cu+].[Cu+] KRFJLUBVMFXRPN-UHFFFAOYSA-N 0.000 claims description 12
- 229940112669 cuprous oxide Drugs 0.000 claims description 12
- 238000000465 moulding Methods 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 8
- 239000008188 pellet Substances 0.000 description 98
- 230000000052 comparative effect Effects 0.000 description 89
- 239000002245 particle Substances 0.000 description 62
- 239000004594 Masterbatch (MB) Substances 0.000 description 55
- 241000700605 Viruses Species 0.000 description 55
- 210000004027 cell Anatomy 0.000 description 50
- -1 dextran sulfate Chemical compound 0.000 description 50
- 239000002202 Polyethylene glycol Substances 0.000 description 47
- 229920001223 polyethylene glycol Polymers 0.000 description 47
- 239000004743 Polypropylene Substances 0.000 description 40
- 229920001155 polypropylene Polymers 0.000 description 40
- 239000010408 film Substances 0.000 description 37
- 239000007788 liquid Substances 0.000 description 35
- 239000000463 material Substances 0.000 description 35
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 34
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 34
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 34
- 230000000813 microbial effect Effects 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
- 229910052751 metal Inorganic materials 0.000 description 21
- 239000002184 metal Substances 0.000 description 21
- 238000012360 testing method Methods 0.000 description 20
- 238000005259 measurement Methods 0.000 description 19
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 19
- 239000002994 raw material Substances 0.000 description 19
- 229910001928 zirconium oxide Inorganic materials 0.000 description 19
- 239000004698 Polyethylene Substances 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 18
- 229920000573 polyethylene Polymers 0.000 description 18
- 150000001336 alkenes Chemical class 0.000 description 17
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 17
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 17
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 16
- 238000010438 heat treatment Methods 0.000 description 16
- 239000012488 sample solution Substances 0.000 description 15
- 239000000344 soap Substances 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 229920013716 polyethylene resin Polymers 0.000 description 11
- 230000008569 process Effects 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 9
- 238000001746 injection moulding Methods 0.000 description 9
- 238000009987 spinning Methods 0.000 description 9
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 8
- NZZFYRREKKOMAT-UHFFFAOYSA-N diiodomethane Chemical compound ICI NZZFYRREKKOMAT-UHFFFAOYSA-N 0.000 description 8
- 229920001971 elastomer Polymers 0.000 description 8
- 239000000806 elastomer Substances 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 239000006185 dispersion Substances 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 238000002074 melt spinning Methods 0.000 description 7
- 239000002121 nanofiber Substances 0.000 description 7
- 239000002344 surface layer Substances 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- 229920002799 BoPET Polymers 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000006096 absorbing agent Substances 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000013207 serial dilution Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 241001263478 Norovirus Species 0.000 description 5
- 239000004677 Nylon Substances 0.000 description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 description 5
- 238000004220 aggregation Methods 0.000 description 5
- 230000002776 aggregation Effects 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 229910052802 copper Inorganic materials 0.000 description 5
- 239000010949 copper Substances 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 239000002075 main ingredient Substances 0.000 description 5
- 229920001778 nylon Polymers 0.000 description 5
- 239000004014 plasticizer Substances 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- 239000003981 vehicle Substances 0.000 description 5
- 230000003612 virological effect Effects 0.000 description 5
- RNFJDJUURJAICM-UHFFFAOYSA-N 2,2,4,4,6,6-hexaphenoxy-1,3,5-triaza-2$l^{5},4$l^{5},6$l^{5}-triphosphacyclohexa-1,3,5-triene Chemical compound N=1P(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP=1(OC=1C=CC=CC=1)OC1=CC=CC=C1 RNFJDJUURJAICM-UHFFFAOYSA-N 0.000 description 4
- 239000004925 Acrylic resin Substances 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 239000003063 flame retardant Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000000415 inactivating effect Effects 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000004898 kneading Methods 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- 150000002736 metal compounds Chemical class 0.000 description 4
- 239000004745 nonwoven fabric Substances 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 239000002861 polymer material Substances 0.000 description 4
- 230000003389 potentiating effect Effects 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 229920001187 thermosetting polymer Polymers 0.000 description 4
- 241000712461 unidentified influenza virus Species 0.000 description 4
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 3
- 229910001369 Brass Inorganic materials 0.000 description 3
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 239000010951 brass Substances 0.000 description 3
- 230000001332 colony forming effect Effects 0.000 description 3
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 238000010894 electron beam technology Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 208000037797 influenza A Diseases 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229910000000 metal hydroxide Inorganic materials 0.000 description 3
- 150000004692 metal hydroxides Chemical class 0.000 description 3
- 229910044991 metal oxide Inorganic materials 0.000 description 3
- 150000004706 metal oxides Chemical class 0.000 description 3
- 150000004972 metal peroxides Chemical class 0.000 description 3
- 229960000907 methylthioninium chloride Drugs 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 229920001721 polyimide Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000011118 polyvinyl acetate Substances 0.000 description 3
- 229920002689 polyvinyl acetate Polymers 0.000 description 3
- 229920000915 polyvinyl chloride Polymers 0.000 description 3
- 239000004800 polyvinyl chloride Substances 0.000 description 3
- 229920002050 silicone resin Polymers 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 229920005992 thermoplastic resin Polymers 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 239000012956 1-hydroxycyclohexylphenyl-ketone Substances 0.000 description 2
- KWVGIHKZDCUPEU-UHFFFAOYSA-N 2,2-dimethoxy-2-phenylacetophenone Chemical compound C=1C=CC=CC=1C(OC)(OC)C(=O)C1=CC=CC=C1 KWVGIHKZDCUPEU-UHFFFAOYSA-N 0.000 description 2
- VVBLNCFGVYUYGU-UHFFFAOYSA-N 4,4'-Bis(dimethylamino)benzophenone Chemical compound C1=CC(N(C)C)=CC=C1C(=O)C1=CC=C(N(C)C)C=C1 VVBLNCFGVYUYGU-UHFFFAOYSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 2
- 241000709661 Enterovirus Species 0.000 description 2
- 241000714201 Feline calicivirus Species 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 229920000271 Kevlar® Polymers 0.000 description 2
- 229920000433 Lyocell Polymers 0.000 description 2
- 229920001407 Modal (textile) Polymers 0.000 description 2
- 241000150452 Orthohantavirus Species 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 229930182556 Polyacetal Natural products 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 239000012773 agricultural material Substances 0.000 description 2
- 238000004378 air conditioning Methods 0.000 description 2
- 239000013566 allergen Substances 0.000 description 2
- 239000012871 anti-fungal composition Substances 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Chemical compound [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- MQDJYUACMFCOFT-UHFFFAOYSA-N bis[2-(1-hydroxycyclohexyl)phenyl]methanone Chemical compound C=1C=CC=C(C(=O)C=2C(=CC=CC=2)C2(O)CCCCC2)C=1C1(O)CCCCC1 MQDJYUACMFCOFT-UHFFFAOYSA-N 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 229910001431 copper ion Inorganic materials 0.000 description 2
- 239000002274 desiccant Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000004761 kevlar Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 244000309711 non-enveloped viruses Species 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920001707 polybutylene terephthalate Polymers 0.000 description 2
- 229920005668 polycarbonate resin Polymers 0.000 description 2
- 239000004431 polycarbonate resin Substances 0.000 description 2
- 229920001225 polyester resin Polymers 0.000 description 2
- 239000004645 polyester resin Substances 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 239000009719 polyimide resin Substances 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920006324 polyoxymethylene Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229920005990 polystyrene resin Polymers 0.000 description 2
- 229920000874 polytetramethylene terephthalate Polymers 0.000 description 2
- 229920005749 polyurethane resin Polymers 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000002964 rayon Substances 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 238000007665 sagging Methods 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 2
- 239000004034 viscosity adjusting agent Substances 0.000 description 2
- 238000004804 winding Methods 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- JNELGWHKGNBSMD-UHFFFAOYSA-N xanthone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3OC2=C1 JNELGWHKGNBSMD-UHFFFAOYSA-N 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- HSKPJQYAHCKJQC-UHFFFAOYSA-N 1-ethylanthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2CC HSKPJQYAHCKJQC-UHFFFAOYSA-N 0.000 description 1
- IVORCBKUUYGUOL-UHFFFAOYSA-N 1-ethynyl-2,4-dimethoxybenzene Chemical compound COC1=CC=C(C#C)C(OC)=C1 IVORCBKUUYGUOL-UHFFFAOYSA-N 0.000 description 1
- BTJPUDCSZVCXFQ-UHFFFAOYSA-N 2,4-diethylthioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC(CC)=CC(CC)=C3SC2=C1 BTJPUDCSZVCXFQ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- UHFFVFAKEGKNAQ-UHFFFAOYSA-N 2-benzyl-2-(dimethylamino)-1-(4-morpholin-4-ylphenyl)butan-1-one Chemical compound C=1C=C(N2CCOCC2)C=CC=1C(=O)C(CC)(N(C)C)CC1=CC=CC=C1 UHFFVFAKEGKNAQ-UHFFFAOYSA-N 0.000 description 1
- ZCDADJXRUCOCJE-UHFFFAOYSA-N 2-chlorothioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC(Cl)=CC=C3SC2=C1 ZCDADJXRUCOCJE-UHFFFAOYSA-N 0.000 description 1
- WVRHNZGZWMKMNE-UHFFFAOYSA-N 2-hydroxy-1-[2-(2-methylpropyl)phenyl]-2-phenylethanone Chemical compound CC(C)CC1=CC=CC=C1C(=O)C(O)C1=CC=CC=C1 WVRHNZGZWMKMNE-UHFFFAOYSA-N 0.000 description 1
- XMLYCEVDHLAQEL-UHFFFAOYSA-N 2-hydroxy-2-methyl-1-phenylpropan-1-one Chemical compound CC(C)(O)C(=O)C1=CC=CC=C1 XMLYCEVDHLAQEL-UHFFFAOYSA-N 0.000 description 1
- NACPTFCBIGBTSJ-UHFFFAOYSA-N 2-hydroxy-2-phenyl-1-(2-propan-2-ylphenyl)ethanone Chemical compound CC(C)C1=CC=CC=C1C(=O)C(O)C1=CC=CC=C1 NACPTFCBIGBTSJ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- UGVRJVHOJNYEHR-UHFFFAOYSA-N 4-chlorobenzophenone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1=CC=CC=C1 UGVRJVHOJNYEHR-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- WQNTXSXCXGWOBT-UHFFFAOYSA-N C=C.C=C.F.F.F.F Chemical group C=C.C=C.F.F.F.F WQNTXSXCXGWOBT-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- 208000006339 Caliciviridae Infections Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000004709 Chlorinated polyethylene Substances 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 241000193449 Clostridium tetani Species 0.000 description 1
- 239000004859 Copal Substances 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000700626 Cowpox virus Species 0.000 description 1
- 241000150230 Crimean-Congo hemorrhagic fever orthonairovirus Species 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 241000725619 Dengue virus Species 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 229920002085 Dialdehyde starch Polymers 0.000 description 1
- 241000710945 Eastern equine encephalitis virus Species 0.000 description 1
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 1
- 208000030820 Ebola disease Diseases 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000190708 Guanarito mammarenavirus Species 0.000 description 1
- 241000782205 Guibourtia conjugata Species 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 241000893570 Hendra henipavirus Species 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 241000724675 Hepatitis E virus Species 0.000 description 1
- 241000709715 Hepatovirus Species 0.000 description 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 241000342334 Human metapneumovirus Species 0.000 description 1
- 241000701806 Human papillomavirus Species 0.000 description 1
- 241000484121 Human parvovirus Species 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 241001500351 Influenzavirus A Species 0.000 description 1
- 241001500350 Influenzavirus B Species 0.000 description 1
- 241001500343 Influenzavirus C Species 0.000 description 1
- 241000712890 Junin mammarenavirus Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241000712902 Lassa mammarenavirus Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241000711828 Lyssavirus Species 0.000 description 1
- 241000712898 Machupo mammarenavirus Species 0.000 description 1
- 241001115401 Marburgvirus Species 0.000 description 1
- 241000712079 Measles morbillivirus Species 0.000 description 1
- 239000004640 Melamine resin Substances 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- CRZQGDNQQAALAY-UHFFFAOYSA-N Methyl benzeneacetate Chemical compound COC(=O)CC1=CC=CC=C1 CRZQGDNQQAALAY-UHFFFAOYSA-N 0.000 description 1
- QPJVMBTYPHYUOC-UHFFFAOYSA-N Methyl benzoate Natural products COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 1
- 241000700559 Molluscipoxvirus Species 0.000 description 1
- 241000700627 Monkeypox virus Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000711386 Mumps virus Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000526636 Nipah henipavirus Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- OFSAUHSCHWRZKM-UHFFFAOYSA-N Padimate A Chemical compound CC(C)CCOC(=O)C1=CC=C(N(C)C)C=C1 OFSAUHSCHWRZKM-UHFFFAOYSA-N 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 241000700639 Parapoxvirus Species 0.000 description 1
- 201000000239 Phlebotomus fever Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004962 Polyamide-imide Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 241001505332 Polyomavirus sp. Species 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000711798 Rabies lyssavirus Species 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 241000710799 Rubella virus Species 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 241000192617 Sabia mammarenavirus Species 0.000 description 1
- 241001138501 Salmonella enterica Species 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241001135555 Sandfly fever Sicilian virus Species 0.000 description 1
- 241000369757 Sapovirus Species 0.000 description 1
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000150288 Sin Nombre orthohantavirus Species 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000000389 T-cell leukemia Diseases 0.000 description 1
- 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000710886 West Nile virus Species 0.000 description 1
- 241000710951 Western equine encephalitis virus Species 0.000 description 1
- 241000710772 Yellow fever virus Species 0.000 description 1
- 241000907316 Zika virus Species 0.000 description 1
- BDGDYAHBIXFCIS-UHFFFAOYSA-N [(2,6-dimethylbenzoyl)-(2,4,4-trimethylpentyl)phosphoryl]-(2,6-dimethylphenyl)methanone Chemical compound CC=1C=CC=C(C)C=1C(=O)P(=O)(CC(CC(C)(C)C)C)C(=O)C1=C(C)C=CC=C1C BDGDYAHBIXFCIS-UHFFFAOYSA-N 0.000 description 1
- GUCYFKSBFREPBC-UHFFFAOYSA-N [phenyl-(2,4,6-trimethylbenzoyl)phosphoryl]-(2,4,6-trimethylphenyl)methanone Chemical compound CC1=CC(C)=CC(C)=C1C(=O)P(=O)(C=1C=CC=CC=1)C(=O)C1=C(C)C=C(C)C=C1C GUCYFKSBFREPBC-UHFFFAOYSA-N 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000180 alkyd Polymers 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 244000309743 astrovirus Species 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- ZJRXSAYFZMGQFP-UHFFFAOYSA-N barium peroxide Chemical compound [Ba+2].[O-][O-] ZJRXSAYFZMGQFP-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 1
- 235000019402 calcium peroxide Nutrition 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- VFHVQBAGLAREND-UHFFFAOYSA-N diphenylphosphoryl-(2,4,6-trimethylphenyl)methanone Chemical compound CC1=CC(C)=CC(C)=C1C(=O)P(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 VFHVQBAGLAREND-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 238000007772 electroless plating Methods 0.000 description 1
- 238000002338 electrophoretic light scattering Methods 0.000 description 1
- 238000009713 electroplating Methods 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001038 ethylene copolymer Polymers 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- YLQWCDOCJODRMT-UHFFFAOYSA-N fluoren-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C2=C1 YLQWCDOCJODRMT-UHFFFAOYSA-N 0.000 description 1
- RMBPEFMHABBEKP-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2C3=C[CH]C=CC3=CC2=C1 RMBPEFMHABBEKP-UHFFFAOYSA-N 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010102 injection blow moulding Methods 0.000 description 1
- 235000014413 iron hydroxide Nutrition 0.000 description 1
- NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical compound [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- FSPSELPMWGWDRY-UHFFFAOYSA-N m-Methylacetophenone Chemical compound CC(=O)C1=CC=CC(C)=C1 FSPSELPMWGWDRY-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000005397 methacrylic acid ester group Chemical group 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 1
- 239000000025 natural resin Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- QGLKJKCYBOYXKC-UHFFFAOYSA-N nonaoxidotritungsten Chemical compound O=[W]1(=O)O[W](=O)(=O)O[W](=O)(=O)O1 QGLKJKCYBOYXKC-UHFFFAOYSA-N 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- FZUGPQWGEGAKET-UHFFFAOYSA-N parbenate Chemical compound CCOC(=O)C1=CC=C(N(C)C)C=C1 FZUGPQWGEGAKET-UHFFFAOYSA-N 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 229920002312 polyamide-imide Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000306 polymethylpentene Polymers 0.000 description 1
- 239000011116 polymethylpentene Substances 0.000 description 1
- 229920006124 polyolefin elastomer Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011970 polystyrene sulfonate Substances 0.000 description 1
- 229960002796 polystyrene sulfonate Drugs 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920003225 polyurethane elastomer Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 238000011045 prefiltration Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003303 reheating Methods 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000013097 stability assessment Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
- ODHXBMXNKOYIBV-UHFFFAOYSA-N triphenylamine Chemical compound C1=CC=CC=C1N(C=1C=CC=CC=1)C1=CC=CC=C1 ODHXBMXNKOYIBV-UHFFFAOYSA-N 0.000 description 1
- 239000002383 tung oil Substances 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 229910001930 tungsten oxide Inorganic materials 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 241000007181 unidentified human coronavirus Species 0.000 description 1
- 229920006337 unsaturated polyester resin Polymers 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 229920003170 water-soluble synthetic polymer Polymers 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 229940051021 yellow-fever virus Drugs 0.000 description 1
- UGZADUVQMDAIAO-UHFFFAOYSA-L zinc hydroxide Chemical compound [OH-].[OH-].[Zn+2] UGZADUVQMDAIAO-UHFFFAOYSA-L 0.000 description 1
- 229910021511 zinc hydroxide Inorganic materials 0.000 description 1
- 229940007718 zinc hydroxide Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
- A01N59/20—Copper
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
- A01N25/10—Macromolecular compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D201/00—Coating compositions based on unspecified macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D5/00—Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
- C09D5/14—Paints containing biocides, e.g. fungicides, insecticides or pesticides
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D7/00—Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
- C09D7/40—Additives
- C09D7/60—Additives non-macromolecular
- C09D7/61—Additives non-macromolecular inorganic
- C09D7/62—Additives non-macromolecular inorganic modified by treatment with other compounds
Definitions
- the present invention relates to an antimicrobial/antiviral composition, and an antimicrobial/antiviral coating and antimicrobial/antiviral resin member using the composition.
- Patent Literature 1 an antiviral spray agent (Patent Literature 1) in which monovalent copper compound microparticles are suspended in a dispersant; an antiviral coating (Patent Literature 2) in which monovalent copper compound microparticles are added to a binder resin; an antimicrobial composition (Patent Literature 3) in which an antiviral agent having copper iodide microparticles coated with a functionalization agent is added; fiber (Patent Literature 4) in which platinum particles having an antiviral property are fixed to a fiber surface by soaking fiber in a platinum nano-colloid aqueous solution; and an antimicrobial/antiviral polymer material (Patent Literature 5) in which copper oxide and cuprous oxide are included.
- Patent Literature 1 the problem in the antiviral spray agent of Patent Literature 1 is that monovalent copper compound microparticles remain at the sprayed site after spraying and the antiviral effect thus persists; however, once the monovalent copper compound microparticles are removed by cleaning, the antiviral spray agent has to be re-sprayed.
- the problem in the antiviral coating of Patent Literature 2 is that although the antiviral effect is high, this high antiviral effect is unlikely to be exerted unless a large volume of monovalent copper compound is dispersed and filled; on the other hand, if a large volume of monovalent copper compound is dispersed or dissolved, characteristics such as coating film strength and tight adhesion deteriorate.
- the problem in the antimicrobial composition of Patent Literature 3 is that although the antimicrobial effect is high, it takes a very long time, for example, from several hours to a day to exert effect, and as a result of which the composition lacks an immediate effect. In addition, long-term storage causes a monovalent copper compound to be oxidized, thereby decreasing the antimicrobial effect.
- the problem in the fiber in which platinum particles are fixed on the surface thereof according to Patent Literature 4 is that there is an antiviral effect, but the immediate effect of inactivating viruses in a short period of time is poor.
- the problem in the antimicrobial/antiviral polymer material of Patent Literature 5 is that no effect is exerted unless antimicrobial/antiviral particles are projected from the polymer surface. Besides, to exert the effect in a short period of time, the number of particles to be projected has to be increased. As a result, there is a need to increase the number of antimicrobial/antiviral particles included in the polymer material.
- an object of the present invention to provide an antimicrobial/antiviral composition having an excellent immediate effect even when the content of monovalent copper compound is low as well as an antimicrobial/antiviral coating and an antimicrobial/antiviral resin member.
- the first aspect of the invention is an antimicrobial/antiviral composition including: a resin; an antimicrobial/antiviral agent including monovalent copper compound microparticles coated with a dispersant; and a hydrophilic compound that is dispersed in the resin and is immiscible with the resin.
- the second aspect of the invention is the antimicrobial/antiviral composition according to the first aspect of the invention, wherein the dispersant is an inorganic compound.
- the third aspect of the invention is the antimicrobial/antiviral composition according to the first or second aspect of the invention, wherein the copper compound microparticles include at least one of cuprous oxide or copper iodide.
- the fourth aspect of the invention is an antimicrobial/antiviral coating including the antimicrobial/antiviral composition according to any one of the first to third aspects of the invention, wherein a contribution of polar component to surface free energy of coating film formed by drying and/or curing is 2.0% or higher and 40.0% or lower.
- the fifth aspect of the invention is an antimicrobial/antiviral resin member including the antimicrobial/antiviral composition according to any one of the first to third aspects of the invention, wherein a contribution of polar component to surface free energy of the antimicrobial/antiviral resin member is 2.0% or higher and 40.0% or lower.
- the sixth aspect of the invention is the antimicrobial/antiviral resin member according to the fifth aspect of the invention, wherein the antimicrobial/antiviral resin member is a molding.
- the seventh aspect of the invention is the antimicrobial/antiviral resin member according to the fifth aspect of the invention, wherein the antimicrobial/antiviral resin member is fiber.
- the eighth aspect of the invention is a method of producing the antimicrobial/antiviral composition according to any one of the first to third aspects of the invention, including the steps of: mixing the resin and the hydrophilic compound to give a mixture; and mixing the mixture and the copper compound microparticles.
- the ninth aspect of the invention is a method of producing the antimicrobial/antiviral resin member according to the sixth aspect of the invention, including the steps of: mixing the resin and the copper compound microparticles to give a first mixture; mixing the resin and the hydrophilic compound to give a second mixture; and mixing the first mixture and the second mixture.
- a hydrophilic compound is dispersed in the resin of the antimicrobial/antiviral composition. Consequently, the hydrophilic compound is dispersed in a coating film of coating containing the antimicrobial/antiviral composition and/or a resin of resin member containing the antimicrobial/antiviral composition.
- the contribution of polar component to surface free energy on a surface of the coating film or the resin member is increased. Accordingly, bacteria and/or viruses having both a hydrophilic group and a hydrophobic group are readily spread and adsorbed on the surface of the coating film or the resin member. This can provide a member having an excellent immediate effect even when the concentration of monovalent copper compound microparticles is low.
- the monovalent copper compound microparticles are coated with a dispersant, aggregation of the copper compound microparticles in the resin can be prevented.
- the copper compound microparticles can be efficiently in contact with bacteria and/or viruses.
- the hydrophilic compound present in the resin readily adsorbs moisture content in the air, a humidity and/or room temperature fluctuation hardly causes an adsorbed moisture content change. This makes it possible to continue eliciting high antimicrobial/antiviral performance.
- An antimicrobial/antiviral composition includes: a resin as a main ingredient; an antimicrobial/antiviral agent containing monovalent copper compound microparticles coated with a dispersant (hereinafter, also simply referred to as copper compound microparticles); and a hydrophilic compound that is dispersed in the resin and is immiscible with the resin.
- a resin as a main ingredient
- an antimicrobial/antiviral agent containing monovalent copper compound microparticles coated with a dispersant hereinafter, also simply referred to as copper compound microparticles
- a hydrophilic compound that is dispersed in the resin and is immiscible with the resin.
- ingredients included in the antimicrobial/antiviral composition according to this embodiment are described.
- the hydrophilic compound contained in the antimicrobial/antiviral composition of this embodiment include: water-soluble synthetic polymers such as polyvinyl alcohol (PVA), polyvinylpyrrolidone (PVP), polyethylene oxide (PEO), hydroxypropyl cellulose (HPC), polyethylene glycol (PEG), polyacrylamide (PAAM), polyacrylic acid (PAA), sodium polyacrylate, polyethyleneimine; and carboxymethyl starch, dialdehyde starch, alginate, polystyrene sulfonate, carboxymethyl cellulose (CMC), polysaccharides, a polyoxyethylene-polyoxypropylene copolymer, poly-N-alkyl acrylamide, hydroxyethyl cellulose, poly-N-isopropyl acrylamide (PNIAAm), chondroitin sulfate, dextran sulfate, dermatan sulfate,
- the hydrophilic compound is characterized in that the hydrophilic compound is immiscible with the below-described resin as a main ingredient of the antimicrobial/antiviral composition and is formed as an independent discontinuous phase in, for instance, a spherical sea-island form, a lamellar form, or a cylindrical form.
- the discontinuous phase of hydrophilic compound is intermixed in the resin as a main ingredient of the antimicrobial/antiviral composition of this embodiment and a phase-separated structure is formed.
- the antimicrobial/antiviral composition when applied to a resin member, the above makes the surface of the resin member hydrophilic.
- phase separation in this embodiment is illustrated.
- discontinuous phases (small domains) caused by hydrophilic compound assembly are micro-dispersed in the hydrophobic resin.
- the hydrophilic compound and the resin are macroscopically uniform but the phase separation occurs microscopically.
- the size of each discontinuous phase composed of the hydrophilic compound is said to be typically 1 ⁇ m or less.
- the hydrophilic compound can be used as long as the hydrophilic compound is present and immiscible with the resin.
- a user can optionally select a resin as a main ingredient of the antimicrobial/antiviral composition of this embodiment if the resin is immiscible with the above hydrophilic compound.
- a resin as a main ingredient of the antimicrobial/antiviral composition of this embodiment if the resin is immiscible with the above hydrophilic compound.
- Specific examples of this resin will be illustrated in the description of an antimicrobial/antiviral coating and/or an antimicrobial/antiviral resin member using the antimicrobial/antiviral composition.
- the antimicrobial/antiviral composition of this embodiment is characterized by further including monovalent copper compound microparticles as an antimicrobial/antiviral agent that is a substance capable of inactivating either microbial cells (e.g., fungi, bacteria) or viruses or the both.
- monovalent copper compound that can be preferably used include cuprous oxide and a copper halide (in particular, copper iodide) from the viewpoints of temporal stability and effect sustainability.
- the shape of the antimicrobial/antiviral agent is not particularly limited and examples can include a powder form, a paste form, a liquid form, and a microparticle form.
- the particle size of the antimicrobial/antiviral agent is not particularly limited and can be optionally set by a person skilled in the art.
- the average particle size is 1 nm or larger and less than 1 ⁇ m. This is because if the average particle size is less than 1 nm, the substance is unstable; and if the average particle size is 1 ⁇ m or larger, the antimicrobial/antiviral effect is lower than the case of less than 1 ⁇ m and stability of the antimicrobial/antiviral composition during storage deteriorates.
- the average particle size herein refers to a volume-average particle size.
- the volume-average particle size can be measured on the basis of, for instance, a laser Doppler method (dynamic/electrophoretic light scattering).
- the measuring device is not particularly limited and a ⁇ -potential/particle size-measuring system (manufactured by OTSUKA ELECTRONICS Co., LTD.), for instance, may be used.
- the antimicrobial/antiviral agent in this embodiment is characterized in that the surface of copper compound microparticle is coated with a dispersant so as to prevent aggregation of the antimicrobial/antiviral agent.
- a dispersant an organic compound such as a polymer-based dispersant, a surfactant, or a plasticizer or an inorganic compound such as a metal soap may be used, if appropriate.
- an inorganic compound is preferably used because the inorganic compound can increase contact with bacteria and/or viruses and the antimicrobial/antiviral effect is thus readily exploited.
- the ⁇ -potential of inorganic compound such as zirconia, aluminum oxide, or titanium oxide is a positive potential at pH 7.
- viruses in general, possess a negative potential. Accordingly, by coating copper compound microparticles with the inorganic compound microparticles, contact between the antimicrobial/antiviral agent and viruses can be increased, readily resulting in expression of the antiviral effect. Further, when the copper compound microparticles are coated with the inorganic compound, the copper compound microparticles are unlikely to be oxidized, so that the antimicrobial/antiviral effect can persist.
- the “coat” herein refers to the presence of a dispersant on at least a part of a surface of each copper compound microparticle.
- a metal soap as the dispersant is a microparticle, excels in dispersion in a resin, and imparts adequate smoothness to the resin.
- a fatty acid such as stearic acid, oleic acid, ricinoleic acid, octylic acid, and lauric acid; and a metal such as lithium, magnesium, calcium, barium, and zinc are used.
- Examples of the inorganic compound include, in addition to the metal soap, a metal hydroxide, a metal oxide, and a metal peroxide.
- Examples of the metal hydroxide include aluminum hydroxide, zirconium hydroxide, zinc hydroxide, and iron hydroxide.
- Examples of the metal oxide include magnesium oxide, barium oxide, calcium oxide, aluminum oxide, tin oxide, titanium oxide, zinc oxide, zirconium oxide, iron oxide, and tungsten oxide.
- Examples of the metal peroxide include barium peroxide, titanium peroxide, and calcium peroxide. Note that these inorganic compounds may be used singly or may be in combination of two or more kinds.
- the sizes of inorganic compound microparticles are not particularly limited and the average particle size is preferably 1.0 nm or larger and 300 nm or less.
- the virus inactivation mechanism by the monovalent copper compound is not necessarily clear at the moment. However, it seems that when a monovalent copper compound comes into contact with water content in the air or in droplets, a monovalent copper ion is eluted; the eluted monovalent copper ion comes into contact with a virus to release an electron; at that time, the generated reactive species give the virus some damage to inactivate the virus.
- viruses are listed for the viruses capable of being inactivated by the antimicrobial/antiviral composition of this embodiment.
- the viruses include rhinovirus, poliovirus, foot-and-mouth disease virus, rotavirus, norovirus, enterovirus, hepatovirus, astrovirus, sapovirus, hepatitis E virus, influenza virus A, B or C, parainfluenza virus, mumps virus (mumps), measles virus, human metapneumovirus, RS virus, nipahvirus, hendravirus, yellow fever virus, dengue virus, Japan encephalitis virus, West Nile virus, hepatitis B or C virus, eastern and western equine encephalitis virus, Onyong-nyong virus, rubella virus, Lassa virus, Junin virus, Machupo virus, Guanarito virus, Sabia virus, Crimean-Congo hemorrhagic fever virus, sandfly
- microbial cells capable of being inactivated by the antimicrobial/antiviral composition according to this embodiment are not particularly limited and various bacteria can be listed regardless of gram-positive or -negative, aerobic, or anaerobic characteristics and so on. Examples include Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus, Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus pertussis, Salmonella enteritidis, Klebsiella pneumoniae, Pseudomonas aeruginosa, Vibrio, Salmonella enterica, Vibrio cholerae, Shigella dysenteriae, Bacillus anthracis, Mycobacterium tuberculosis, Clostridium botulinum, Clostridium tetani , and Streptococcus.
- a resin which is a main ingredient of the above-described antimicrobial/antiviral composition
- a hydrophilic compound for the mixing procedure, it is possible to use a mixer, a homogenizer, a bead mill, a ball mill, a three-roll mill, or another instrument.
- the antimicrobial/antiviral composition of this embodiment may be optionally blended with an additional additive(s) (e.g., a flame retardant, a flame retardant aid, a stabilizer, a UV absorber, a plasticizer, and/or a lubricant), a pigment, a filler, and/or another ingredient.
- an additional additive(s) e.g., a flame retardant, a flame retardant aid, a stabilizer, a UV absorber, a plasticizer, and/or a lubricant
- the copper compound microparticles used in this embodiment are ground to particles in nano-order by using, for instance, a jet mill, a hammer mill, a ball mill, a vibration mill, or a bead mill.
- the grinding procedure is not particularly limited and both dry and wet processes may be utilized.
- an inorganic compound for coating the copper compound microparticles is added. After the inorganic compound is added, the copper compound microparticles and the inorganic compound are in contact with each other and are crushed. Then, the inorganic compound with a smaller particle size occurs. At the same time, electrostatic attraction causes the inorganic compound to be attached to the surface of each copper compound microparticle.
- an antimicrobial/antiviral agent in which the copper compound microparticles are coated with the inorganic compound.
- This antimicrobial/antiviral agent and a mixture of a resin and a hydrophilic compound are mixed to yield an antimicrobial/antiviral composition.
- the procedure for coating the surface of each copper compound microparticle with a metal hydroxide, a metal oxide, or a metal peroxide as the inorganic compound may include: dispersing copper compound microparticles in an aqueous solution containing such a dissolved metal compound so as to chemically adsorb the metal compound on the surface of each copper compound microparticle; or dispersing copper compound microparticles in a solvent containing a dispersed metal compound so as to precipitate the metal compound on the surface of each copper compound microparticle.
- Examples of another procedure include a mechanochemical procedure.
- This procedure is a process for embedding child particles into mother particles by applying strong pressure to core mother particles (in this embodiment, copper compound microparticles) and child particles (in this embodiment, an inorganic compound) covering the mother particles by using a rolling ball mill, a high-speed rotary grinder, a high-speed flow impact grinder, a medium-agitating mill, or a mechanical fusion device.
- the copper compound microparticles, which are mother particles should be beforehand ground to a desired particle size by the above process.
- Examples of an apparatus allowing for preparation of the mother particles and the child particles include: a rotary blade type such as a super mixer from KAWATA MFG. CO., LTD.; and a shaker type such as a paint shaker from ASADA IRON WORKS. CO., LTD., a Hybridization System (registered trademark) manufactured by NARA MACHINERY CO., LTD., a Mechanofusion (registered trademark) from Hosokawa Micron Group, or a medium flow dryer.
- the apparatus is not particularly limited to these devices.
- the devices allowing for both grinding and coating of child particles may be used, including an automated mortar, a high-speed rotary grinder, a high-speed flow impact grinder, or a rolling ball mill. In this case, it is unnecessary to beforehand crush copper compound microparticles which are mother particles.
- the antimicrobial/antiviral coating of an embodiment of the invention includes the above-mentioned antimicrobial/antiviral composition. Then, the antimicrobial/antiviral coating of this embodiment is characterized in that in a dried and/or cured state (i.e., in a coating film state), the contribution (hereinafter, referred to as polar contribution R ⁇ p) of polar component ⁇ sp to surface free energy ⁇ s is 2.0% or higher and 40.0% or lower.
- the surface free energy ⁇ s refers to surplus energy of a molecule (or an atom) present on a solid surface or liquid surface when compared to that of a molecule (or an atom) present inside the solid or liquid.
- the surface free energy ⁇ s is defined by the following Formula (1); and the polar contribution R ⁇ p is defined by the following Formula (2).
- ⁇ sp is the polar component in the surface free energy ⁇ s
- ⁇ sd is the non-polar component in the surface free energy ⁇ s.
- the surface free energy ⁇ s, the non-polar component ⁇ sd, and the polar component ⁇ sp are values when the antimicrobial/antiviral coating of this embodiment is in a dried and/or cured state.
- a surface of coating film which is subject to measurement, in a dried and/or cured state is coated with a measurement liquid (each of water or diiodomethane is used) to measure the contact angle ( ⁇ ) of each measurement liquid.
- a measurement liquid each of water or diiodomethane is used
- the value obtained for the contact angle and the following Formula (3) are used to calculate the polar component ⁇ sp and the non-polar component ⁇ sd.
- ⁇ Contact angle of measurement liquid on a surface of coating film in a dried and/or cured state
- ⁇ L Surface tension of measurement liquid (water or diiodomethane)
- ⁇ Ld Non-polar component of surface free energy of measurement liquid (water or diiodomethane)
- ⁇ Lp Polar component of surface free energy of measurement liquid (water or diiodomethane)
- ⁇ sd Non-polar component of surface free energy of coating film in a dried and/or cured state
- ⁇ sp Polar component of surface free energy of coating film in a dried and/or cured state
- the surface tension ⁇ L, the non-polar component ⁇ Ld, and the polar component ⁇ Lp may be measured beforehand.
- the polar component ⁇ sp and the non-polar component ⁇ sd can be calculated.
- the surface free energy ⁇ s can be calculated.
- this surface free energy ⁇ s and the polar component ⁇ sp may be assigned to the above Formula (2) to calculate the polar contribution R ⁇ p.
- the surface free energy ⁇ s may be comparable. Even in this case, as the polar contribution R ⁇ p increases, the antimicrobial/antiviral effect becomes higher. The rationale is not necessarily clear at the moment. However, it seems that as the polar contribution R ⁇ p increases, microbial cells and/or viruses attached to the coating film surface spread more readily. This causes the antimicrobial/antiviral agent to easily contact the microbial cells and the viruses, thereby enhancing the antimicrobial/antiviral effect.
- a material to be coated with the antimicrobial/antiviral coating of this embodiment may have a high intrinsic polar contribution R ⁇ p. Even in this case, the antimicrobial/antiviral effect is not increased unless the hydrophilic compound is included. The rationale is unclear, but it seems that if the hydrophilic compound is not included, microbial cells and viruses are unlikely to spread on the coating film surface and are thus not readily in contact with the antimicrobial/antiviral agent.
- the polar contribution R ⁇ p of coating film in a dried and/or cured state may be adjusted by how much the hydrophilic compound is added. In order to increase the antimicrobial effect and the antiviral effect, it is preferable that the polar contribution R ⁇ p of a coating film is 2.0% or higher and 40.0% or lower. More preferably, the polar contribution R ⁇ p is 5% or higher and 30% or lower.
- the polar contribution R ⁇ p When the polar contribution R ⁇ p is less than 2.0%, the antimicrobial effect and the antiviral effect are insufficient compared to the case where the polar contribution R ⁇ p is 2.0% or higher. To improve the antimicrobial effect and the antiviral effect, it is more preferable that the polar contribution R ⁇ p is 5% or higher. Meanwhile, when the polar contribution R ⁇ p exceeds 40%, the antimicrobial effect and the antiviral effect are not much elevated compared to the case where the polar contribution R ⁇ p is 40% or lower. Because of the above, it is preferable that the polar contribution R ⁇ p is 40% or lower.
- the dried state of an antimicrobial/antiviral coating herein means a state in which when the antimicrobial/antiviral coating is subjected to drying treatment and so on, the antimicrobial/antiviral coating residual content is substantially in a solid state.
- the cured state of an antimicrobial/antiviral coating means a state in which when the antimicrobial/antiviral coating is coated/dried, etc., to form a coating film, dust, etc., may be attached to the surface thereof; and even in this case, the dust, etc., is not incorporated into the coating film. The attached dust, etc., may be easily removed by blowing the air.
- the cured state of an antimicrobial/antiviral coating herein indicates a state of at least a surface of a coating film and does not necessarily means that the inside of the coating film is completely cured.
- a user can optionally select a resin as a base of the antimicrobial/antiviral coating of this embodiment if the resin is immiscible with the above-mentioned hydrophilic compound.
- a resin as a base of the antimicrobial/antiviral coating of this embodiment if the resin is immiscible with the above-mentioned hydrophilic compound.
- Specific examples used include thermoplastic resins, thermosetting resins, and radiation curable resins that can be cured by irradiation with an electron beam and/or UV light, etc. These resins may be in combination of two or more kinds.
- thermoplastic resins examples include: olefin-based resins such as polyethylene, polypropylene, chlorinated polyethylene; polystyrene resin, polyvinyl acetate resin, polyurethane resin, polyester resin; copolymers containing acrylic acid, acrylic acid ester, methacrylic acid, or methacrylic acid ester as a backbone; acrylic styrene resin, fluorine-based resin; cellulose-based resins such as nitrocellulose and ethyl cellulose; drying oil such as castor oil, linseed oil, or Tung oil; and natural resins such as shellac and copal.
- thermosetting resins include phenol resin, epoxy resin, melamine resin, urea resin, unsaturated polyester resin, acrylic silicone resin, alkyd resin, polyurethane resin, thermosetting acrylic resin, and thermosetting polyimide resin.
- the radiation (e.g., an electron beam or UV light) curable resins are monomers, oligomers, or polymers.
- the radiation (e.g., an electron beam or UV light) curable resins are monomers, oligomers, or polymers.
- preferable examples include multifunctional (meth)acrylate compounds such as multifunctional (meth)acrylate monomers, multifunctional (meth)acrylate oligomers, or multifunctional (meth)acrylate polymers.
- a photopolymerization initiator may be added depending on the needs.
- photopolymerization initiator examples include anthraquinone, acetophenone, isopropyl benzoin ether, isobutyl benzoin ether, ethylanthraquinone, carbazole, xanthone, 4-chlorobenzophenone, o-benzoyl methylbenzoate, 2,4-diethylthioxantone, 2-chlorothioxanthone, 2,2-dimethoxy-1,2-diphenylethan-1-one, p-dimethylamino benzoic acid isoamyl ester, p-dimethylamino benzoic acid ethyl ester, 2,2-dimethoxy-2-phenylacetophenone, 1-hydroxycyclohexyl phenyl ketone, 2-hydroxy-2-methyl-1-phenyl-propane-1-one, 1-hydroxycyclohexyl phenyl ketone, 2-benzyl-2-dimethylamino-1(4
- the antimicrobial/antiviral coating of this embodiment may be used to coat each different target member to give the antimicrobial/antiviral performance.
- Examples of the target member include fiber structures, films, and sheets.
- Examples of the fiber structures capable of having a coating film include woven fabrics and nonwoven fabrics. Specific application examples of them include masks, filters for air conditioners, filters for air cleaners, filters for vacuum cleaners, filters for ventilators, vehicle filters, air conditioning filters, clothing, protective clothing, bedding, window screen nets, and henhouse nets.
- Each fiber structure may include a polymer material (e.g., polyester, polyethylene, polypropylene, polyvinyl chloride, polyethylene terephthalate, polybutylene terephthalate, polytetramethylene terephthalate, nylon, acryl, polytetrafluoroethylene, polyvinyl alcohol, Kevlar, polyacrylic acid, polymethyl methacrylate, rayon, Cupra, Tencel, polynosic, acetate, triacetate, cotton, hemp, wool, silk, bamboo) and/or fiber containing a metal (e.g., aluminum, iron, stainless steel, brass, copper, tungsten, titanium).
- a metal e.g., aluminum, iron, stainless steel, brass, copper, tungsten, titanium
- materials for the films include those containing a resin such as polyester, polyethylene, polypropylene, polyamide, polyvinyl chloride, polyvinylidene fluoride, polyvinyl alcohol, polyvinyl acetate, polyimide, polyamide imide, polytetrafluoroethylene, or an ethylene tetrafluoride-ethylene copolymer.
- a resin such as polyester, polyethylene, polypropylene, polyamide, polyvinyl chloride, polyvinylidene fluoride, polyvinyl alcohol, polyvinyl acetate, polyimide, polyamide imide, polytetrafluoroethylene, or an ethylene tetrafluoride-ethylene copolymer.
- the sheets include polymer-made sheets (e.g., polycarbonate resin sheets, film vinyl chloride sheets, fluorine resin sheets, polyethylene sheets, silicone resin sheets, nylon sheets, ABS sheets, urethane sheets) or sheets containing a metal (e.g., titanium, aluminum, stainless steel, magnesium, brass).
- a metal e.g., titanium, aluminum, stainless steel, magnesium, brass.
- films and/or sheets include wallpapers and windows, ceilings, vehicle seats, doors, window shades, chairs, sofas, floor materials, facilities in which microbial cells and/or viruses are involved, train/vehicle interior materials, interior materials for buildings such as hospitals, agricultural materials, or roller shutters. They are applicable to various fields.
- the antimicrobial/antiviral coating of this embodiment may be directly applied to a panel, a construction decorative material, an interior material, a writing instrument, a handrail, a strap, a phone, a toy, or a molding such as a door handle to form a film (coating film).
- the polymer-made molding include moldings formed by using ABS, polycarbonate, nylon, polypropylene, polystyrene, polyacetal, polyester, or the like.
- examples of the metal molding include moldings formed by using aluminum, zinc, magnesium, brass, stainless steel, titanium, or the like.
- the surface of the metal molding may have a metal thin film, a coating, or a printing, etc., prefabricated by electroplating or electroless plating.
- a mixture obtained by mixing a resin and a hydrophilic compound and a ground antimicrobial/antiviral agent (copper compound microparticles coated by a dispersant) are prepared. Then, they are mixed to yield an antimicrobial/antiviral coating of this embodiment.
- the antimicrobial/antiviral coating may be optionally blended with an additional additive(s) (e.g., a flame retardant, a flame retardant aid, a stabilizer, a UV absorber, a plasticizer, and/or a lubricant), a pigment, a filler, and/or another ingredient.
- the antimicrobial/antiviral resin member according to an embodiment of the invention includes the above-mentioned antimicrobial/antiviral composition. Then, the antimicrobial/antiviral resin member of this embodiment is characterized in that the contribution (hereinafter, referred to as polar contribution R ⁇ p) of polar component ⁇ sp to surface free energy ⁇ s of the resin member is 2.0% or higher and 40.0% or lower.
- the polar contribution R ⁇ p of the antimicrobial/antiviral resin member of this embodiment is defined by the above Formulas (1) to (3) as described regarding the above-mentioned antimicrobial/antiviral coating.
- a solvent may be removed and dried by heating and reheating and/or irradiation with infrared light, UV light, an electron beam, a ⁇ ray, or the like may cause curing. Because of this, in the above Formulas (1) and (2), the surface free energy ⁇ s, the non-polar component ⁇ sd, and the polar component ⁇ sp are values when the antimicrobial/antiviral resin member of this embodiment is in a dried and/or cured state.
- a surface of the antimicrobial/antiviral resin member is used instead of the coating film surface.
- the polar contribution R ⁇ p of coating film of the antimicrobial/antiviral coating when the polar contribution R ⁇ p is less than 2.0%, the antimicrobial/antiviral effect is insufficient when compared to the case where the polar contribution R ⁇ p is 2.0% or higher. Meanwhile, when the polar contribution R ⁇ p exceeds 40.0%, the antimicrobial/antiviral effect is not much elevated compared to the case where the polar contribution R ⁇ p is 40.0% or lower. Because of the above, it is preferable that the polar contribution R ⁇ p is 40.0% or lower.
- the polar contribution R ⁇ p of the antimicrobial/antiviral resin member is preferably 5.0% or higher and 30.0% or lower and more preferably 10.0% or higher and 20.0% or lower. To improve the antimicrobial/antiviral effect, the polar contribution R ⁇ p is preferably 5.0% or higher and more preferably 10.0% or higher.
- the content of the hydrophilic compound in the antimicrobial/antiviral resin member of this embodiment is not particularly limited and can be set by those skilled in the art, if appropriate.
- the content is preferably 0.01 mass % or higher and 50.0 mass % or lower with respect to 100 mass % of the antimicrobial/antiviral resin member.
- the polar contribution R ⁇ p of the antimicrobial/antiviral resin member cannot be adequately increased when compared to the case where the content of the hydrophilic compound is 0.01 mass % or higher.
- the strength of the antimicrobial/antiviral resin member is lower than that of the case where the content of the hydrophilic compound is 50.0 mass % or lower. Further, when the content of the hydrophilic compound is 0.01 mass % or higher and 50.0 mass % or lower and the content of the hydrophilic compound is larger than the content of the antimicrobial/antiviral agent, the strength of the antimicrobial/antiviral resin member may be decreased. Thus, it is preferable that the content of the hydrophilic compound is below the content of the antimicrobial/antiviral agent.
- the base resin for the antimicrobial/antiviral resin member is not particularly limited as long as the resin is immiscible with the above-stated hydrophilic compound.
- examples include: thermoplastic resins such as polyester resin, polyethylene resin, polypropylene resin, polystyrene resin, ABS resin, AS resin, EVA resin, polymethylpentene resin, polyvinyl chloride resin, polyvinylidene chloride resin, methyl polyacrylate resin, polyvinyl acetate resin, polyamide resin, polyimide resin, polycarbonate resin, polyethylene terephthalate resin, polytetramethylene terephthalate resin, polybutylene terephthalate resin, polyacetal resin, polyacrylate resin, polysulfone resin, nylon resin, acrylic resin, polyvinylidene fluoride resin, polyethylene tetrafluoroethylene resin, polytetrafluoroethylene resin, polyvinyl alcohol resin, Kevlar (registered trademark), and polymethyl methacrylate resin; silicone resin
- a liquid hydrophilic compound may be used. In this case, foaming, etc., may occur. Thus, it is preferable to use a solid hydrophilic compound.
- the antimicrobial/antiviral resin member of this embodiment may contain the above-stated antimicrobial/antiviral composition.
- an additional ingredient(s) may be included and the shape thereof is also not limited.
- the antimicrobial/antiviral resin member of this embodiment may be a molded product and may be shaped like a sheet, a film, fiber, a cloth, a mesh (net structure), a honeycomb, a nonwoven fabric, or the like.
- nano-fiber fiber with an average fiber diameter of 5 nm or larger and less than 1 ⁇ m
- the average fiber diameter refers to the average of the fiber diameters of plural nano-fibers.
- the fiber diameter of nano-fiber may be measured, using a microscope, by examining a nano-fiber image.
- nano-fibers are observed with an electron microscope, etc., and some of the nano-fibers are selected at random in the resulting observed image. Then, image processing software is used to measure the fiber diameter of each nano-fiber and the average of the respective fiber diameters can be calculated.
- first master batch pellet and the second master batch pellet are melted and kneaded.
- the kneaded material is formed as a predetermined shape to obtain an antimicrobial/antiviral resin member of this embodiment.
- the first master batch pellet and the second master batch pellet are separately prepared and are then melted and kneaded. This makes it possible to avoid contact between the antimicrobial/antiviral agent and the hydrophilic compound in the antimicrobial/antiviral resin member.
- the first master batch pellet is prepared as follows. First, ground copper compound microparticles and a dispersant are mixed. After the surface of each copper compound microparticle is coated with the dispersant to produce an antimicrobial/antiviral agent, this antimicrobial/antiviral agent and a resin pellet are mixed. Then, a kneading extruder is used to disperse the antimicrobial/antiviral agent in the resin pellet. Alternatively, ground copper compound microparticles and a dispersant are mixed with a resin pellet. Next, a kneading extruder is used and the dispersant is so attracted to the surrounding of the copper compound microparticles during kneading.
- the copper compound microparticles are coated with the dispersant to produce an antimicrobial/antiviral agent.
- This antimicrobial/antiviral agent is also dispersed in the resin pellet.
- a pelletizer is used to finely cut the antimicrobial/antiviral agent-containing resin. In this way, the first master batch pellet containing the antimicrobial/antiviral agent is obtained. Note that the proportion (concentration) of the antimicrobial/antiviral agent at the time of manufacture of the first master batch pellet may be set by those skilled in the art, if appropriate.
- the second master batch pellet is prepared as follows. First, a hydrophilic compound and a resin pellet are mixed at a prescribed weight ratio to yield a mixture.
- the resin pellet the same material as the resin pellet used during manufacture of the first master batch pellet is used. The resulting mixture is melted and kneaded to yield the second master batch pellet.
- a molding machine is used to mold a material obtained by melting and kneading the first and second master batch pellets. Then, it is possible to obtain an antimicrobial/antiviral resin member in which the antimicrobial/antiviral agent and the hydrophilic compound are dispersed in the base resin.
- the antimicrobial/antiviral resin member according to this embodiment can be molded by a process such as injection molding or blow molding.
- examples of the antimicrobial/antiviral resin member according to this embodiment include, in addition to the molded product, a sheet-shaped, a film-shaped, a fiber-shaped, a cloth-shaped, a meshed (net structure), a honeycomb-shaped, or a nonwoven fabric-shaped form, etc.
- the antimicrobial/antiviral resin member can be manufactured in various forms (e.g., a shape, dimension) fit for their usage.
- a T-die process, an inflation process, or the like may be used for the formation.
- the antimicrobial/antiviral resin member is manufactured like fiber, melt spinning, etc., may be used for the formation.
- the antimicrobial/antiviral resin member is manufactured like a nonwoven fabric, it can be manufactured by an existing manufacturing process such as spun-bonding.
- the antimicrobial/antiviral resin member according to this embodiment may contain, as an additive(s), for instance, a plasticizer, a desiccant, a curing agent, an antiskinning agent, a leveling agent, an anti-sagging agent, an antifungal, a UV absorber, a heat ray absorber, a lubricant, a surfactant, a thickener, a viscosity modifier, a stabilizer, and/or a drying modifier.
- additives may be used singly or may be used in combination of two or more kinds.
- other antiviral composition, antimicrobial composition, antifungal composition, anti-allergen composition, catalyst, antireflection material, and/or material having heat shield characteristics may be added and used.
- the antimicrobial/antiviral resin member of this embodiment is applicable to: fibers; agricultural materials such as house films, tunnel house films; moldings such as trays used in plant factories; panels; construction decorative materials; interior materials; writing instruments; handrails; straps; phones; toys; door handles; stationery such as clear folders or label tapes; sheets; shrinking materials that are contracted when heated; construction decorative materials (e.g., chairs, sofas, exterior wall materials, sashes, doors, window shades, ceiling plates, floor plates, windows); interior materials (e.g., wallpapers, carpets, resin tiles); interior materials for trains or vehicles; clothing; innerwear; socks; gloves; shoe covers; footwear such as shoes; bedding materials (e.g., pajamas, mats, sheets, pillows, pillowcases, blankets, towelkets, futons, futon covers); caps; handkerchiefs; towels; rugs; curtains; filters for air cleaners, air conditioners, ventilators, vacuum cleaners, fans, or the like; various water surface-contacting members (e.g.
- a first master batch pellet which is a resin pellet containing the antimicrobial/antiviral agent
- a second master batch pellet which is obtained by mixing a hydrophilic compound and a resin pellet at a prescribed weight ratio, is prepared.
- the first master batch pellet and the second master batch pellet are mixed, melted, and kneaded to produce a spinning raw material.
- the resulting spinning raw material may be subjected to a melt spinning step to obtain fiber in this embodiment.
- the melt spinning process is not limited to a specific process and a known process may be used.
- the spinning temperature may be optionally selected from a temperature range fit for fiber material if the range is set such that discharge from a spinneret is possible while the resin viscosity is appropriately low, neither resin deterioration nor thermal decomposition occurs, the spinning step is not markedly unstabilized, and fiber with high strength can be obtained by subsequent stretching processing.
- the melt spinning step spinning raw material is discharged from a spinneret; the discharged fibrous spinning raw material is cooled and solidified to yield fiber. Specifically, the discharged spinning raw material is cooled to a solidification temperature or lower and solidified in a medium such as the air, water, or glycerol.
- a medium such as the air, water, or glycerol.
- the air temperature and the wind speed may be arbitrarily set. However, to suppress the molecular orientation, it is desirable that the wind speed should be low and the temperature is not too low. If the degree of molecular orientation at the cooling time point is high, fiber is not readily stretched when a heating/stretching step is carried out as the next step. Consequently, the antimicrobial/antiviral effect may be unlikely to be obtained.
- the winding rate may be set to a given rate. In this regard, however, when the winding rate is lower than the free-fall rate of molten unstretched yarn, uniform unstretched yarn is not necessarily obtained, leading to a decrease in stretchability. Note that when a heating/stretching step is carried out as the next step, the solidified yarn is not necessarily wound and may be subjected, as it is, to the heating/stretching step.
- the heating/stretching step is a step of heating and stretching fiber (unstretched yarn) wound in the spinning step.
- the heating/stretching step may include multiple stretching steps.
- the stretch factors in the respective stretching steps are multiplied to give a total stretch factor. Note that when the heating/stretching step includes a single stretching step, the stretch factor in this single stretching step is a total stretch factor.
- the fiber in this embodiment may be heated and stretched to express much better antimicrobial/antiviral performance and thus can efficiently inactivate bacteria and/or viruses attached to the fiber surface, etc.
- the heating and stretching can cause the antimicrobial/antiviral effect to increase.
- the mechanism of markedly increasing the antimicrobial/antiviral effect by heating and stretching is not necessarily clear at the moment. However, the following rationale may be considered.
- a surface layer portion of fiber in a molten state during the spinning step is directly cooled and solidified once the cooling begins.
- the antimicrobial/antiviral agent which is present in a portion (inner layer portion) inside of the fiber relative to the surface layer portion, is structured such that the agent is not readily in contact with water content outside the fiber.
- the inner layer portion is cooled via the surface layer portion and solidified. Accordingly, the cooling speed of the inner layer portion is lower than the cooling speed of the surface layer portion. This may cause the fiber structure of the surface layer portion to be different from the fiber structure of the inner layer portion.
- the stretching is conducted under a heating condition at a glass transition point or higher. This causes the fiber structure of the surface layer portion to be a fiber structure in which the antimicrobial/antiviral agent and water content outside the fiber easily come into contact. On top of that, the heating and stretching make the fiber structure of the surface layer portion close to the fiber structure of the inner layer portion. This seems to impart some effect on the surface charges and/or DNA of bacteria and/or viruses, thereby inactivating them.
- the stretching process is not particularly limited and a known stretching process such as hot roll drawing, hot plate drawing, tubular stretching, stretch-blowing, or laser stretching may be optionally adopted.
- hot roll drawing is used for the heating and stretching, the rotational speeds of hot rolls, which are combined in multiple stages, are changed. Accordingly, unstretched yarn can be stretched at a high factor.
- the stretch factor may be optionally selected depending on the fineness of material to be stretched, and the total stretch factor is set usually to 3.0 or higher and 7.0 or less and preferably 4.0 or higher and 6.0 or less.
- the stretch factor is 3.0 or higher and 7.0 or less, the molecule is more oriented to give stronger fiber.
- the stretch factor is less than 3.0, the antimicrobial/antiviral effect is lower than that in the case of the stretch factor of 3.0 or higher and the resulting fiber strength is lowered.
- the stretch factor exceeds 7.0, the stretching tension becomes extremely high. This may frequently cause yarn rapture, leading to a decrease in yarn productivity.
- the fiber in the antimicrobial/antiviral resin member according to this embodiment may have a core-sheath structure.
- the core for instance, may be formed using a regular resin (antimicrobial/antiviral agent-free resin) and the sheath may be formed using a resin containing the antimicrobial/antiviral agent and/or a hydrophilic compound. This not only can improve the fiber strength, but also provides an advantage such that the content of the antimicrobial/antiviral agent may be decreased.
- a resin for the core and a resin for the sheath may be the same or different resins.
- the shape of cross-section perpendicular to the longitudinal direction of the fiber in the core-sheath structure is not particularly limited, and the cross-sectional shape is preferably circular and the core and the sheath are preferably shaped like concentric circles.
- the ratio of the area of the core to the area of the sheath in the cross-section perpendicular to the longitudinal direction of the fiber is not particularly limited and may be set by a user, if appropriate.
- the fiber in the antimicrobial/antiviral resin member according to this embodiment may contain, as an additive(s), for instance, a plasticizer, a desiccant, a curing agent, an antiskinning agent, a leveling agent, an anti-sagging agent, an antifungal, a UV absorber, a heat ray absorber, a lubricant, a surfactant, a thickener, a viscosity modifier, a stabilizer, and/or a drying modifier.
- additives may be used singly or may be used in combination of two or more kinds.
- other antiviral composition, antimicrobial composition, antifungal composition, anti-allergen composition, catalyst, antireflection material, and/or material having heat shield characteristics may be added and used.
- the fiber in the antimicrobial/antiviral resin member according to this embodiment may be used for woven fabrics, knitted fabrics, nonwoven fabrics, paper materials such as mixed papers, and so on. Then, this fiber can be used for various products including: sheet-shaped products (e.g., clothing, bedding, bedding materials, masks, handkerchiefs, towels, rugs, curtains, exterior wall materials, construction decorative materials, interior materials); filters for air cleaners, air conditioners, ventilators, vacuum cleaners, fans, air-conditioning, or vehicles; fishing nets such as fish preserve or fixed nets; filters for water treatment; filters for drinking water; filters for ballast water treatment; protective clothing; protection nets; insect screens; or henhouse nets.
- the fiber in this embodiment is therefore a useful material that makes it possible to provide a variety of excellent products in various fields.
- polyvinylpyrrolidone (PVP) and an olefin-based resin were provided and mixed in a toluene solvent. After the mixture was dispersed using a ball mill, the above-described copper iodide particles coated with zirconium oxide were added and further dispersed to produce an antimicrobial/antiviral coating.
- PVP polyvinylpyrrolidone
- the mass % of each raw material included in the antimicrobial/antiviral coating is as designated in the following Table 1.
- Each resulting antimicrobial/antiviral coating was applied onto a polypropylene sheet (with a thickness of 200 ⁇ m) by using a bar coater (#20) and then dried to obtain a sheet painted with the antimicrobial/antiviral coating. At that time, the thickness of the coating film was 2 ⁇ m.
- a sheet painted with an antimicrobial/antiviral coating was obtained under the same conditions as for Example 1 except that polyethylene glycol (PEG) was used instead of polyvinylpyrrolidone.
- PEG polyethylene glycol
- the mass % of each raw material included in the antimicrobial/antiviral coating was as designated in the following Table 1.
- a sheet painted with an antimicrobial/antiviral coating was obtained under the same conditions as for Example 1 except that a urethane-based resin was used instead of the olefin-based resin.
- the mass % of each raw material included in the antimicrobial/antiviral coating was as designated in the following Table 1.
- a sheet painted with an antimicrobial/antiviral coating was obtained under the same conditions as for Example 5 except that polyethylene glycol was used instead of polyvinylpyrrolidone.
- the mass % of each raw material included in the antimicrobial/antiviral coating was as designated in the following Table 1.
- a sheet painted with an antimicrobial/antiviral coating was obtained under the same conditions as for Example 1 except that an acryl-based resin was used instead of the olefin-based resin.
- the mass % of each raw material included in the antimicrobial/antiviral coating was as designated in the following Table 1.
- the resulting antimicrobial/antiviral coating was applied onto a polypropylene sheet (with a thickness of 200 ⁇ m) by using a bar coater (#20) and then dried to obtain a sheet painted with the antimicrobial/antiviral coating. At that time, the thickness of the coating film was 2 ⁇ m.
- a sheet painted with an antimicrobial/antiviral coating was obtained under the same conditions as for Example 8 except that a urethane-based resin was used instead of the olefin-based resin.
- the mass % of each raw material included in the antimicrobial/antiviral coating was as designated in the following Table 1.
- a sheet painted with an antimicrobial/antiviral coating was obtained under the same conditions as for Example 8 except that an acryl-based resin was used instead of the olefin-based resin and polyethylene glycol was used instead of polyvinylpyrrolidone.
- the mass % of each raw material included in the antimicrobial/antiviral coating was as designated in the following Table 1.
- a just olefin-based resin was a material, mixed in a toluene solvent, and dispersed with a ball mill to produce a coating.
- the mass % of the olefin-based resin is 100 mass % as designated in the following Table 2.
- the resulting coating was applied onto a polypropylene sheet (with a thickness of 200 ⁇ m) by using a bar coater (#20) and then dried to obtain a sheet painted with the coating. At that time, the thickness of the coating film was 2 ⁇ m.
- a sheet painted with a coating was obtained under the same conditions as for Example 1 except that the mixing and dispersion were carried out while copper iodide particles coated with zirconium oxide were not included.
- the mass % of each raw material included in this coating was as designated in the following Table 2.
- a sheet painted with a coating was obtained under the same conditions as for Example 1 except that the mixing and dispersion were carried out while polyvinylpyrrolidone was not included.
- the mass % of each raw material included in this coating was as designated in the following Table 2.
- a sheet painted with a coating was obtained under the same conditions as for Example 5 except that the mixing and dispersion were carried out while copper iodide particles coated with zirconium oxide were not included.
- the mass % of each raw material included in this coating was as designated in the following Table 2.
- a sheet painted with a coating was obtained under the same conditions as for Example 5 except that the mixing and dispersion were carried out while polyvinylpyrrolidone was not included.
- the mass % of each raw material included in this coating was as designated in the following Table 2.
- a sheet painted with a coating was obtained under the same conditions as for Example 10 except that the mixing and dispersion were carried out while cuprous oxide coated with zirconium oxide were not included.
- the mass % of each raw material included in this coating was as designated in the following Table 2.
- a sheet painted with a coating was obtained under the same conditions as for Example 10 except that the mixing and dispersion were carried out while polyethylene glycol was not included.
- the mass % of each raw material included in this coating was as designated in the following Table 2.
- Tables 1 and 2 list the respective components of the antimicrobial/antiviral coatings of Examples 1 to 10 and Comparative Examples 1 to 7 described.
- influenza virus influenza A/Kitakyushu/159/93(H3N2) cultured using MDCK cells was used.
- Each sheet (50 mm ⁇ 50 mm) painted with the antimicrobial/antiviral coating of each one of Examples 1 to 10 and Comparative Examples 1 to 7 was placed on a plastic dish. Next, 100 ⁇ L of virus liquid diluted with PBS was added dropwise thereto and reacted at 25° C. for 15 min. At that time, an upper surface of the sheet test product was covered with a PET film (40 mm ⁇ 40 mm) such that the area of contact between the virus liquid and the sheet test product was made constant. Then, testing was conducted. After 10-min reaction, 900 ⁇ L of SCDLP broth was added so as to stop the reaction. Then, the virus was purged by pipetting.
- MEM diluent was used to dilute each post-reaction virus liquid to from 10 ⁇ 1 to 10 ⁇ 5 (10-fold serial dilution) to prepare sample solutions. Then, 100 ⁇ L of each sample solution was seeded onto MDCK cells cultured on a dish. The cells seeded with the sample solution were allowed to stand for 60 min in an incubator at 34° C. and 5% CO 2 . After the virus was adsorbed on the cells, 0.7% agar broth was overlaid and the virus was cultured for 48 h in the incubator at 34° C. and 5% CO 2 .
- Each sheet (50 mm ⁇ 50 mm) painted with the antimicrobial/antiviral coating of each one of Examples 1 to 10 and Comparative Examples 1 to 7 was placed on a plastic dish. Next, 100 ⁇ L of microbial cell liquid, which was diluted with 1/500 NB broth until the cell count reached 2.5 ⁇ 10 5 to 10 ⁇ 10 6 , was added dropwise thereto and reacted at 35° C. for 10 min. At that time, an upper surface of the sheet test product was covered with a PET film (40 mm ⁇ 40 mm) such that the area of contact between the microbial cell liquid and the sheet test product was made constant. Then, testing was conducted. After 15-min reaction, 4 mL of SCDLP broth was added so as to stop the reaction.
- Each sheet painted with the antimicrobial/antiviral coating of each one of Examples 1 to 10 and Comparative Examples 1 to 7 was used to measure the contact angle of each measurement liquid (water or diiodomethane was used) by using a contact angle meter (a solid/liquid interface analyzer DropMaster300, manufactured by Kyowa Interface Science, Inc.).
- a contact angle meter a solid/liquid interface analyzer DropMaster300, manufactured by Kyowa Interface Science, Inc.
- Each measurement result was used to calculate a polar component ⁇ sp and a non-polar component ⁇ sd by using the above Formula (3) and to calculate the surface free energy ⁇ s of each coating film by using the above Formula (1).
- the above Formula (2) was used to calculate a polar contribution R ⁇ p.
- Tables 3 and 4 collectively provide the respective measurement results of the sheets painted with the antimicrobial/antiviral coatings of Examples 1 to 10 and Comparative Examples 1 to 7 described.
- Example 1 2.1 1.7 39.5 9.6
- Example 2 1.6 1.2 39.0 8.9
- Example 3 ⁇ 1.3 ⁇ 1.0 39.9 17.6
- Example 4 ⁇ 1.3 ⁇ 1.0 39.6 12.5
- Example 5 ⁇ 1.3 ⁇ 1.0 40.4 25.7
- Example 6 ⁇ 1.3 ⁇ 1.0 40.0 24.5
- Example 7 ⁇ 1.3 ⁇ 1.0 40.2 26.1
- Example 8 2.5 2.4 38.7 17.0
- Example 9 2.6 2.8 40.4 24.0
- Example 10 ⁇ 1.3 ⁇ 1.0 39.4 24.6 Control 5.8 5.6 — —
- Example 11 The coating prepared using the procedure in Example 3 was that in Example 11.
- the coating in Comparative Example 8 was a coating adjusted using the same procedure as in Example 3 except that zirconium oxide particles (manufactured by NIHON DENKO, Inc.), which are inorganic compound microparticles, were not used, that is, copper iodide particles not coated with zirconium oxide particles were used.
- zirconium oxide particles manufactured by NIHON DENKO, Inc.
- Example 11 An accelerated test was carried out such that the samples of Example 11 and Comparative Example 8 were left for 3 months under conditions at a temperature of 50° C. and a humidity of 90%. Then, a color change (color difference ⁇ E) between before and after the test was determined with a color-difference meter. Table 5 shows the results.
- Example 11 Each coating of Example 11 or Comparative Example 8 was applied onto a polypropylene sheet and dried in the same procedure as in Example 3.
- the antimicrobial/antiviral performance of each resulting sheet was evaluated by the above-described evaluation protocol. The results are shown in Table 6.
- a dry grinder Nano Jetmizer NJ-100B (manufactured by Aishin Nano Technologies CO., LTD.) was used to grind commercially available copper (I) iodide powder (manufactured by NIHON KAGAKU SANGYO CO., LTD.) to an average particle size of 150 nm to yield copper iodide particles.
- a polyethylene (PE) resin pellet (manufactured by Asahi Kasei Chemicals Corporation), as a base resin, was added, such that the content of the copper iodide particles mixed with the dispersant was 40 mass % with respect to the whole master batch pellet, to prepare a mixture.
- the resulting mixture was fed to a twin-screw melt kneader to obtain a first master batch pellet.
- a polyethylene resin pellet (manufactured by Asahi Kasei Chemicals Corporation), as a base resin, was added, such that the content of polyethylene glycol (with a molecular weight of 20,000) was 20 mass % with respect to the whole master batch pellet, to prepare a mixture.
- the resulting mixture was fed to a twin-screw melt kneader to obtain a second master batch pellet.
- a polyethylene resin pellet, the first master batch pellet, and the second master batch pellet were mixed so as to have 5 mass % of copper iodide and 3 mass % of polyethylene glycol (with a molecular weight of 20,000) with respect to the whole injection-molded member.
- An injection molding machine was used to perform injection molding, and an injection-molded member, as an antimicrobial/antiviral resin member, was then obtained.
- a polypropylene (PP) resin pellet as a base resin was added, such that the content of the copper iodide particles mixed with the dispersant (metal soap) was 40 mass % with respect to the whole master batch pellet, to prepare a mixture.
- the resulting mixture was fed to a twin-screw melt kneader to obtain a master batch pellet.
- An injection-molded member as an antimicrobial/antiviral resin member was obtained under the same conditions as for Example 12 except that the polypropylene (PP) resin pellet, the master batch pellet, and polyethylene glycol were mixed so as to have 5 mass % of copper iodide and 5 mass % of polyethylene glycol with respect to the whole injection-molded member.
- PP polypropylene
- An injection-molded member as an antimicrobial/antiviral resin member was obtained under the same conditions as for Example 13 except that polyvinylpyrrolidone (with a molecular weight of 10,000) was used instead of polyethylene glycol used in Example 13.
- ABS resin pellet as a base resin was added, such that the content of copper iodide particles ground with the dispersant was 30 mass % with respect to the whole master batch pellet, to prepare a mixture.
- the resulting mixture was fed to a twin-screw melt kneader to obtain a master batch pellet.
- ABS resin pellet, the master batch pellet, and polyvinylpyrrolidone were mixed so as to have 5 mass % of copper iodide and 3 mass % of polyvinylpyrrolidone (with a molecular weight of 10,000) with respect to the whole injection-molded member.
- An injection molding machine was used to perform injection molding, and an injection-molded member, as an antimicrobial/antiviral resin member, was then obtained.
- An injection-molded member as an antimicrobial/antiviral resin member was obtained under the same conditions as for Example 15 except that the ABS resin pellet, the master batch pellet, and polyvinylpyrrolidone were mixed so as to have 5 mass % of copper iodide and 5 mass % of polyvinylpyrrolidone (with a molecular weight of 10,000) with respect to the whole injection-molded member.
- polypropylene (PP) resin pellet was coated, using a Henschel mixer (registered trademark), with a slurry (40 mass %) of copper iodide particles coated with zirconium oxide having an average particle size of 140 nm as used in Example 1. Next, the coated polypropylene resin pellet was fed to a twin-screw melt kneader to yield a first master batch pellet.
- PP polypropylene
- a polypropylene (PP) resin was added, such that the content of polyethylene glycol (with a molecular weight of 20,000) was 20 mass % with respect to the whole master batch pellet, to prepare a mixture.
- the resulting mixture was fed to a twin-screw melt kneader to obtain a second master batch pellet.
- a polypropylene (PP) resin pellet, the first master batch pellet, and the second master batch pellet were mixed so as to have 5 mass % of copper iodide and 5 mass % of polyethylene glycol (with a molecular weight of 20,000) with respect to the whole injection-molded member.
- An injection molding machine was used to perform injection molding, and an injection-molded member as an antimicrobial/antiviral resin member was then obtained.
- a just polypropylene resin pellet was a material and an injection molding machine was used to obtain an injection-molded member.
- An injection-molded member was obtained under the same conditions as for Example 13 except that the polypropylene resin pellet and the master batch pellet were mixed such that polyethylene glycol was not include and the content of copper iodide was 5 mass % with respect to the whole injection-molded member.
- An injection-molded member was obtained under the same conditions as for Example 13 except that the polypropylene resin pellet and polyethylene glycol were mixed such that copper iodide and the dispersant (metal soap) were not included and the content of polyethylene glycol was 10 mass % with respect to the whole injection-molded member.
- a just ABS resin pellet was a material and an injection molding machine was used to obtain an injection-molded member.
- An injection-molded member was obtained under the same conditions as for Example 15 except that the ABS resin pellet and the master batch pellet were mixed such that polyvinylpyrrolidone was not include and the content of copper iodide was 5 mass % with respect to the whole injection-molded member.
- An injection-molded member was obtained under the same conditions as for Example 15 except that the ABS resin pellet and polyvinylpyrrolidone were mixed such that copper iodide and the dispersant (metal soap) were not include and the content of polyvinylpyrrolidone was 10 mass % with respect to the whole injection-molded member.
- a polyethylene resin pellet (manufactured by Asahi Kasei Chemicals Corporation) as a base resin was added, such that the content of the resulting copper iodide particles was 40 mass % with respect to the whole master batch pellet, to prepare a mixture.
- the resulting mixture was fed to a twin-screw melt kneader to obtain a master batch pellet.
- a polyethylene resin pellet, the master batch pellet, and polyethylene glycol were mixed so as to have 5 mass % of copper iodide and 1 mass % of polyethylene glycol (with a molecular weight of 20,000) with respect to the whole sheet-shaped member.
- a T-die extruder was used to obtain a sheet-shaped member as an antimicrobial/antiviral resin member with a thickness of 100 ⁇ m.
- a sheet-shaped member as an antimicrobial/antiviral resin member was obtained under the same conditions as for Example 18 except that the polyethylene resin pellet, the master batch pellet, and polyethylene glycol were mixed so as to have 5 mass % of copper iodide and 5 mass % of polyethylene glycol with respect to the whole sheet-shaped member.
- the resulting mixture was fed to a twin-screw melt kneader to obtain a master batch pellet.
- An antimicrobial/antiviral sheet-shaped member was obtained under the same conditions as for Example 18 except that the polypropylene resin pellet, the master batch pellet, and polyethylene glycol were mixed so as to have 5 mass % of copper iodide and 5 mass % of polyethylene glycol with respect to the whole sheet-shaped member.
- a just polyethylene resin pellet was a material and a T-die extruder was used to obtain a sheet-shaped member with a thickness of 100 ⁇ m.
- a sheet-shaped member was obtained under the same conditions as for Example 18 except that the polyethylene resin pellet and the master batch pellet were mixed such that polyethylene glycol was not include and the content of copper iodide was 5 mass % with respect to the whole sheet-shaped member.
- a sheet-shaped member was obtained under the same conditions as for Example 18 except that the polyethylene resin pellet and polyethylene glycol were mixed such that copper iodide and the dispersant (metal soap) were not included and the content of polyethylene glycol was 5 mass % with respect to the whole sheet-shaped member.
- a sheet-shaped member was obtained under the same conditions as for Example 18 except that the polyethylene resin pellet and polyvinylpyrrolidone were mixed such that copper iodide and the dispersant (metal soap) were not included and the content of polyvinylpyrrolidone instead of polyethylene glycol was 5 mass % with respect to the whole sheet-shaped member.
- Table 8 lists the components of the sheet-shaped members of Examples 18 to 20 and Comparative Examples 15 to 18 described.
- influenza virus influenza A/Kitakyushu/159/93(H3N2)
- MDCK cells a virus that has been typically and frequently used as a virus alternative for norovirus, was used.
- Injection-molded members of Examples 12 to 17 and Comparative Examples 9 to 14 or sheet-shaped members (50 mm ⁇ 50 mm) of Examples 18 to 20 and Comparative Examples 15 to 18 were each placed on a plastic dish.
- 100 ⁇ L of virus liquid diluted with PBS was added dropwise thereto and reacted at 25° C. for 15 min.
- an upper surface of the sheet test product was covered with a PET film (40 mm ⁇ 40 mm) such that the area of contact between the virus liquid and the sheet test product was made constant.
- testing was conducted.
- 900 ⁇ L of SCDLP broth was added so as to stop the reaction. Then, the virus was purged by pipetting.
- MEM diluent was used to dilute each post-reaction virus liquid to from 10 ⁇ 1 to 10 ⁇ 5 (10-fold serial dilution) to prepare sample solutions. Then, 100 ⁇ L of each sample solution was seeded onto MDCK cells cultured on a dish. The cells seeded with the sample solution were allowed to stand for 60 min in an incubator at 34° C. and 5% CO 2 . After the virus was adsorbed on the cells, 0.7% agar broth was overlaid and the virus was cultured for 48 h in the incubator at 34° C. and 5% CO 2 .
- Staphylococcus aureus cultured in NB broth was used as gram-positive bacteria.
- E. coli cultured in NB broth was used as gram-negative bacteria.
- Injection-molded members of Examples 12 to 17 and Comparative Examples 9 to 14 or sheet-shaped members (50 mm ⁇ 50 mm) of Examples 18 to 20 and Comparative Examples 15 to 18 were each placed on a plastic dish.
- 100 ⁇ L of microbial cell liquid which was diluted with 1/500 NB broth until the microbial cell count reached 2.5 ⁇ 10 5 to 10 ⁇ 10 6 , was added dropwise thereto and reacted at 35° C. for 60 min.
- an upper surface of the sheet test product was covered with a PET film (40 mm ⁇ 40 mm) such that the area of contact between the microbial cell liquid and the sheet test product was made constant. Then, testing was conducted.
- a contact angle meter (a solid/liquid interface analyzer DropMaster300, manufactured by Kyowa Interface Science, Inc.) was used to measure the contact angle of each measurement liquid (water or diiodomethane was used) on a surface of each one of the injection-molded members of Examples 12 to 17 and Comparative Examples 9 to 14 or the sheet-shaped members of Examples 18 to 20 and Comparative Examples 15 to 18. These measurement results were used to calculate a polar component ⁇ sp and a non-polar component ⁇ sd by using the above Formula (3) and to calculate the surface free energy ⁇ s of each injection-molded member or each sheet-shaped member by using the above Formula (1). In addition, the above Formula (2) was used to calculate a polar contribution R ⁇ p.
- Table 9 collectively provides the measurement results of the antimicrobial/antiviral resin members that are the injection-molded members of Examples 12 to 17 and Comparative Examples 9 to 14 described.
- Table 10 collectively provides the measurement results of the antimicrobial/antiviral resin members that are the sheet-shaped members of Examples 18 to 20 and Comparative Examples 15 to 18.
- a polypropylene resin pellet (manufactured by Asahi Kasei Chemicals Corporation), as a base resin, was added thereto so as to have 40 mass % of the resulting copper iodide.
- the resulting mixture was fed to a twin-screw melt kneader to obtain a copper iodide master batch pellet.
- polyethylene glycol manufactured by SANYO CHEMICAL, LTD.
- a polypropylene resin pellet manufactured by Asahi Kasei Chemicals Corporation
- the resulting mixture was fed to a twin-screw melt kneader to obtain a polyethylene glycol master batch pellet.
- a polypropylene resin pellet, the copper iodide master batch pellet, and the polyethylene glycol master batch pellet were mixed using a tumbler so as to have 1 mass % of copper iodide and 3 mass % of polyethylene glycol.
- melt spinning was carried out to obtain monofilament fiber, which was an antimicrobial/antiviral resin member with a fineness of 300 D.
- Example 21 Regarding a copper iodide master batch pellet and a polyethylene glycol master batch pellet, those prepared in Example 21 were used.
- a polypropylene resin pellet, the copper iodide master batch pellet, and the polyethylene glycol master batch pellet were mixed using a tumbler so as to have 1 mass % of copper iodide and 3 mass % of polyethylene glycol in its sheath.
- a polypropylene resin pellet was used as its core.
- melt spinning was carried out to obtain monofilament fiber that had a core-sheath structure and was an antimicrobial/antiviral resin member having a core-sheath area ratio of 7/3 and a fineness of 300 D.
- Example 21 Regarding a copper iodide master batch pellet, the one prepared in Example 21 was used.
- a polypropylene resin pellet and the copper iodide master batch pellet were mixed using a tumbler so as to have 1 mass % of copper iodide. Next, melt spinning was carried out to obtain monofilament fiber with a fineness of 300 D.
- influenza virus influenza A/Kitakyushu/159/93(H3N2)
- MDCK cells a virus inactivation performance of monofilament fiber
- feline calicivirus which has been typically and frequently used as a virus alternative for norovirus, was used.
- Monofilament fiber which was an antimicrobial/antiviral resin member of each of Example 21 or 22 or Comparative Example 19, was wound around the middle of a glass plate (50 mm ⁇ 100 mm) as a single layer with a width of 60 mm without any gap.
- 200 ⁇ L of virus liquid diluted with sterile water was added dropwise and was reacted therewith at 25° C. for 15 min.
- an upper surface of the monofilament fiber test product was covered with a PET film (40 mm ⁇ 40 mm) such that the area of contact between the virus liquid and the monofilament fiber test product was made constant. Then, testing was conducted.
- each sample solution was seeded onto MDCK cells cultured on a dish. The cells seeded with the sample solution were allowed to stand for 60 min in an incubator at 34° C. and 5% CO 2 . After the virus was adsorbed on the cells, 0.7% agar broth was overlaid and the virus was cultured for 48 h in the incubator at 34° C. and 5% CO 2 .
- Monofilament fiber which was an antimicrobial/antiviral resin member of each of Example 21 or 22 or Comparative Example 19, was wound around the middle of a glass plate (50 mm ⁇ 100 mm) as a single layer with a width of 60 mm without any gap.
- 100 ⁇ L of microbial cell liquid diluted with sterile water was added dropwise and was reacted therewith at 35° C. for 15 min.
- an upper surface of the monofilament fiber test product was covered with a PET film (40 mm ⁇ 40 mm) such that the area of contact between the microbial cell liquid and the monofilament fiber test product was made constant.
- a contact angle meter (an automated micro-contact meter MCA-3, manufactured by Kyowa Interface Science, Inc.) was used to measure the contact angle of each measurement liquid (water or diiodomethane was used) on a surface of the monofilament fiber of Example 21 or 22 or Comparative Example 19. These measurement results were used to calculate a polar component ⁇ sp and a non-polar component ⁇ sd by using the above Formula (3) and to calculate the surface free energy ⁇ s of each monofilament fiber by using the above Formula (1). In addition, the above Formula (2) was used to calculate a polar contribution R ⁇ p.
- Table 12 collectively provides the measurement results regarding the monofilament fibers of Examples 21 to 22 and Comparative Example 19 described.
- any antimicrobial/antiviral composition which is included in an antimicrobial/antiviral coating and/or an antimicrobial/antiviral resin member, according to the invention elicits antimicrobial and/or antiviral performance.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Zoology (AREA)
- Pest Control & Pesticides (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Environmental Sciences (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Toxicology (AREA)
- Dispersion Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
- The present invention relates to an antimicrobial/antiviral composition, and an antimicrobial/antiviral coating and antimicrobial/antiviral resin member using the composition.
- Recently, new viral infections have increasingly become threatening. For instance, infections caused by virus such as SARS (severe acute respiratory syndrome), norovirus, and avian influenza virus have prevailed. Meanwhile, Ebola hemorrhagic fever prevailed in West Africa in 2013. According to announcement of the World Health Organization (WHO), among 27,550 infection cases including suspected infection 11,235 of dead cases have been reported by 2015.
- In addition, norovirus and/or influenza infections in institutions such as hospitals and nursing homes and nosocomial infection due to drug-resistant bacteria such as MRSA have also prevailed. As a result, urgent countermeasures against the infections should be implemented.
- In view of such a background, products should be developed that can easily impart a potent function of inactivating viruses and/or bacteria.
- To provide a solution to the problems, the following has been developed, including an antiviral spray agent (Patent Literature 1) in which monovalent copper compound microparticles are suspended in a dispersant; an antiviral coating (Patent Literature 2) in which monovalent copper compound microparticles are added to a binder resin; an antimicrobial composition (Patent Literature 3) in which an antiviral agent having copper iodide microparticles coated with a functionalization agent is added; fiber (Patent Literature 4) in which platinum particles having an antiviral property are fixed to a fiber surface by soaking fiber in a platinum nano-colloid aqueous solution; and an antimicrobial/antiviral polymer material (Patent Literature 5) in which copper oxide and cuprous oxide are included.
-
- Patent Literature 1: JP 2010-239897 A
- Patent Literature 2: JP 2010-168578 A
- Patent Literature 3: JP 2014-519504 A
- Patent Literature 4: JP 2014-122457 A
- Patent Literature 5: JP 5457504 B2
- Unfortunately, the problem in the antiviral spray agent of Patent Literature 1 is that monovalent copper compound microparticles remain at the sprayed site after spraying and the antiviral effect thus persists; however, once the monovalent copper compound microparticles are removed by cleaning, the antiviral spray agent has to be re-sprayed. The problem in the antiviral coating of Patent Literature 2 is that although the antiviral effect is high, this high antiviral effect is unlikely to be exerted unless a large volume of monovalent copper compound is dispersed and filled; on the other hand, if a large volume of monovalent copper compound is dispersed or dissolved, characteristics such as coating film strength and tight adhesion deteriorate.
- In addition, the problem in the antimicrobial composition of Patent Literature 3 is that although the antimicrobial effect is high, it takes a very long time, for example, from several hours to a day to exert effect, and as a result of which the composition lacks an immediate effect. In addition, long-term storage causes a monovalent copper compound to be oxidized, thereby decreasing the antimicrobial effect. Further, the problem in the fiber in which platinum particles are fixed on the surface thereof according to Patent Literature 4 is that there is an antiviral effect, but the immediate effect of inactivating viruses in a short period of time is poor. Furthermore, the problem in the antimicrobial/antiviral polymer material of Patent Literature 5 is that no effect is exerted unless antimicrobial/antiviral particles are projected from the polymer surface. Besides, to exert the effect in a short period of time, the number of particles to be projected has to be increased. As a result, there is a need to increase the number of antimicrobial/antiviral particles included in the polymer material.
- Here, to solve the above problems, it is an object of the present invention to provide an antimicrobial/antiviral composition having an excellent immediate effect even when the content of monovalent copper compound is low as well as an antimicrobial/antiviral coating and an antimicrobial/antiviral resin member.
- Specifically, the first aspect of the invention is an antimicrobial/antiviral composition including: a resin; an antimicrobial/antiviral agent including monovalent copper compound microparticles coated with a dispersant; and a hydrophilic compound that is dispersed in the resin and is immiscible with the resin.
- Meanwhile, the second aspect of the invention is the antimicrobial/antiviral composition according to the first aspect of the invention, wherein the dispersant is an inorganic compound.
- In addition, the third aspect of the invention is the antimicrobial/antiviral composition according to the first or second aspect of the invention, wherein the copper compound microparticles include at least one of cuprous oxide or copper iodide.
- In addition, the fourth aspect of the invention is an antimicrobial/antiviral coating including the antimicrobial/antiviral composition according to any one of the first to third aspects of the invention, wherein a contribution of polar component to surface free energy of coating film formed by drying and/or curing is 2.0% or higher and 40.0% or lower.
- In addition, the fifth aspect of the invention is an antimicrobial/antiviral resin member including the antimicrobial/antiviral composition according to any one of the first to third aspects of the invention, wherein a contribution of polar component to surface free energy of the antimicrobial/antiviral resin member is 2.0% or higher and 40.0% or lower.
- In addition, the sixth aspect of the invention is the antimicrobial/antiviral resin member according to the fifth aspect of the invention, wherein the antimicrobial/antiviral resin member is a molding.
- In addition, the seventh aspect of the invention is the antimicrobial/antiviral resin member according to the fifth aspect of the invention, wherein the antimicrobial/antiviral resin member is fiber.
- In addition, the eighth aspect of the invention is a method of producing the antimicrobial/antiviral composition according to any one of the first to third aspects of the invention, including the steps of: mixing the resin and the hydrophilic compound to give a mixture; and mixing the mixture and the copper compound microparticles.
- In addition, the ninth aspect of the invention is a method of producing the antimicrobial/antiviral resin member according to the sixth aspect of the invention, including the steps of: mixing the resin and the copper compound microparticles to give a first mixture; mixing the resin and the hydrophilic compound to give a second mixture; and mixing the first mixture and the second mixture.
- According to the invention, a hydrophilic compound is dispersed in the resin of the antimicrobial/antiviral composition. Consequently, the hydrophilic compound is dispersed in a coating film of coating containing the antimicrobial/antiviral composition and/or a resin of resin member containing the antimicrobial/antiviral composition. As a result, the contribution of polar component to surface free energy on a surface of the coating film or the resin member is increased. Accordingly, bacteria and/or viruses having both a hydrophilic group and a hydrophobic group are readily spread and adsorbed on the surface of the coating film or the resin member. This can provide a member having an excellent immediate effect even when the concentration of monovalent copper compound microparticles is low. In addition, because the monovalent copper compound microparticles are coated with a dispersant, aggregation of the copper compound microparticles in the resin can be prevented. Thus, the copper compound microparticles can be efficiently in contact with bacteria and/or viruses. Further, because the hydrophilic compound present in the resin readily adsorbs moisture content in the air, a humidity and/or room temperature fluctuation hardly causes an adsorbed moisture content change. This makes it possible to continue eliciting high antimicrobial/antiviral performance.
- Hereinafter, an antimicrobial/antiviral composition according to an embodiment of the invention will be described in detail.
- An antimicrobial/antiviral composition according to an embodiment of the invention includes: a resin as a main ingredient; an antimicrobial/antiviral agent containing monovalent copper compound microparticles coated with a dispersant (hereinafter, also simply referred to as copper compound microparticles); and a hydrophilic compound that is dispersed in the resin and is immiscible with the resin.
- First, ingredients included in the antimicrobial/antiviral composition according to this embodiment are described. Examples of the hydrophilic compound contained in the antimicrobial/antiviral composition of this embodiment include: water-soluble synthetic polymers such as polyvinyl alcohol (PVA), polyvinylpyrrolidone (PVP), polyethylene oxide (PEO), hydroxypropyl cellulose (HPC), polyethylene glycol (PEG), polyacrylamide (PAAM), polyacrylic acid (PAA), sodium polyacrylate, polyethyleneimine; and carboxymethyl starch, dialdehyde starch, alginate, polystyrene sulfonate, carboxymethyl cellulose (CMC), polysaccharides, a polyoxyethylene-polyoxypropylene copolymer, poly-N-alkyl acrylamide, hydroxyethyl cellulose, poly-N-isopropyl acrylamide (PNIAAm), chondroitin sulfate, dextran sulfate, dermatan sulfate, a methyl vinyl ether-maleic anhydride copolymer, an ethylene-vinyl acetate copolymer, and an acrylamide-acrylate copolymer such as a dimethylacrylamide-glycidyl methacrylate copolymer.
- The hydrophilic compound is characterized in that the hydrophilic compound is immiscible with the below-described resin as a main ingredient of the antimicrobial/antiviral composition and is formed as an independent discontinuous phase in, for instance, a spherical sea-island form, a lamellar form, or a cylindrical form. The discontinuous phase of hydrophilic compound is intermixed in the resin as a main ingredient of the antimicrobial/antiviral composition of this embodiment and a phase-separated structure is formed. When the antimicrobial/antiviral composition is applied to a coating, the above makes the surface of a coating film hydrophilic after the coating is dried or cured. Alternatively, when the antimicrobial/antiviral composition is applied to a resin member, the above makes the surface of the resin member hydrophilic. These results are characterized in that as described below, how well viruses and/or microbial cells spread on the above surface is enhanced and the antimicrobial/antiviral effect is thus improved.
- Here, the phase separation in this embodiment is illustrated. In the case of this embodiment, after the resin and the hydrophilic compound are mixed, discontinuous phases (small domains) caused by hydrophilic compound assembly are micro-dispersed in the hydrophobic resin. The hydrophilic compound and the resin are macroscopically uniform but the phase separation occurs microscopically. The size of each discontinuous phase composed of the hydrophilic compound is said to be typically 1 μm or less. In this embodiment, regardless of whether the hydrophilic compound is in a discontinuous phase (small domain) or a continuous phase in which the discontinuous phases are fused to one another, the hydrophilic compound can be used as long as the hydrophilic compound is present and immiscible with the resin.
- Meanwhile, a user can optionally select a resin as a main ingredient of the antimicrobial/antiviral composition of this embodiment if the resin is immiscible with the above hydrophilic compound. Specific examples of this resin will be illustrated in the description of an antimicrobial/antiviral coating and/or an antimicrobial/antiviral resin member using the antimicrobial/antiviral composition.
- The antimicrobial/antiviral composition of this embodiment is characterized by further including monovalent copper compound microparticles as an antimicrobial/antiviral agent that is a substance capable of inactivating either microbial cells (e.g., fungi, bacteria) or viruses or the both. Specific examples of the monovalent copper compound that can be preferably used include cuprous oxide and a copper halide (in particular, copper iodide) from the viewpoints of temporal stability and effect sustainability. The shape of the antimicrobial/antiviral agent is not particularly limited and examples can include a powder form, a paste form, a liquid form, and a microparticle form.
- The particle size of the antimicrobial/antiviral agent (copper compound microparticles) is not particularly limited and can be optionally set by a person skilled in the art. Here, it is preferable that the average particle size is 1 nm or larger and less than 1 μm. This is because if the average particle size is less than 1 nm, the substance is unstable; and if the average particle size is 1 μm or larger, the antimicrobial/antiviral effect is lower than the case of less than 1 μm and stability of the antimicrobial/antiviral composition during storage deteriorates. Note that the average particle size herein refers to a volume-average particle size. The volume-average particle size can be measured on the basis of, for instance, a laser Doppler method (dynamic/electrophoretic light scattering). The measuring device is not particularly limited and a ζ-potential/particle size-measuring system (manufactured by OTSUKA ELECTRONICS Co., LTD.), for instance, may be used.
- Further, the antimicrobial/antiviral agent in this embodiment is characterized in that the surface of copper compound microparticle is coated with a dispersant so as to prevent aggregation of the antimicrobial/antiviral agent. As the dispersant, an organic compound such as a polymer-based dispersant, a surfactant, or a plasticizer or an inorganic compound such as a metal soap may be used, if appropriate. In this embodiment, an inorganic compound is preferably used because the inorganic compound can increase contact with bacteria and/or viruses and the antimicrobial/antiviral effect is thus readily exploited. For instance, the ζ-potential of inorganic compound such as zirconia, aluminum oxide, or titanium oxide is a positive potential at pH 7. Meanwhile, viruses, in general, possess a negative potential. Accordingly, by coating copper compound microparticles with the inorganic compound microparticles, contact between the antimicrobial/antiviral agent and viruses can be increased, readily resulting in expression of the antiviral effect. Further, when the copper compound microparticles are coated with the inorganic compound, the copper compound microparticles are unlikely to be oxidized, so that the antimicrobial/antiviral effect can persist. The “coat” herein refers to the presence of a dispersant on at least a part of a surface of each copper compound microparticle.
- A metal soap as the dispersant is a microparticle, excels in dispersion in a resin, and imparts adequate smoothness to the resin. For the metal soap, a fatty acid such as stearic acid, oleic acid, ricinoleic acid, octylic acid, and lauric acid; and a metal such as lithium, magnesium, calcium, barium, and zinc are used.
- Examples of the inorganic compound include, in addition to the metal soap, a metal hydroxide, a metal oxide, and a metal peroxide. Examples of the metal hydroxide include aluminum hydroxide, zirconium hydroxide, zinc hydroxide, and iron hydroxide. Examples of the metal oxide include magnesium oxide, barium oxide, calcium oxide, aluminum oxide, tin oxide, titanium oxide, zinc oxide, zirconium oxide, iron oxide, and tungsten oxide. Examples of the metal peroxide include barium peroxide, titanium peroxide, and calcium peroxide. Note that these inorganic compounds may be used singly or may be in combination of two or more kinds. The sizes of inorganic compound microparticles are not particularly limited and the average particle size is preferably 1.0 nm or larger and 300 nm or less.
- The virus inactivation mechanism by the monovalent copper compound is not necessarily clear at the moment. However, it seems that when a monovalent copper compound comes into contact with water content in the air or in droplets, a monovalent copper ion is eluted; the eluted monovalent copper ion comes into contact with a virus to release an electron; at that time, the generated reactive species give the virus some damage to inactivate the virus.
- Regardless of the kind of genome and/or the presence or absence of envelope, various viruses are listed for the viruses capable of being inactivated by the antimicrobial/antiviral composition of this embodiment. Examples of the viruses include rhinovirus, poliovirus, foot-and-mouth disease virus, rotavirus, norovirus, enterovirus, hepatovirus, astrovirus, sapovirus, hepatitis E virus, influenza virus A, B or C, parainfluenza virus, mumps virus (mumps), measles virus, human metapneumovirus, RS virus, nipahvirus, hendravirus, yellow fever virus, dengue virus, Japan encephalitis virus, West Nile virus, hepatitis B or C virus, eastern and western equine encephalitis virus, Onyong-nyong virus, rubella virus, Lassa virus, Junin virus, Machupo virus, Guanarito virus, Sabia virus, Crimean-Congo hemorrhagic fever virus, sandfly fever/hantavirus, hantavirus, Sin Nombre virus, rabies virus, Ebola virus, Marburg virus, bat lyssavirus, human T cell leukemia virus, human immunodeficiency virus, human coronavirus, SARS coronavirus, human parvovirus, polyoma virus, human papilloma virus, adenovirus, herpes virus, varicella-zoster virus, EB virus, cytomegalovirus, smallpox virus, monkeypox virus, cowpox virus, molluscipoxvirus virus, parapox virus, and zika virus.
- In addition, microbial cells capable of being inactivated by the antimicrobial/antiviral composition according to this embodiment are not particularly limited and various bacteria can be listed regardless of gram-positive or -negative, aerobic, or anaerobic characteristics and so on. Examples include Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus, Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus pertussis, Salmonella enteritidis, Klebsiella pneumoniae, Pseudomonas aeruginosa, Vibrio, Salmonella enterica, Vibrio cholerae, Shigella dysenteriae, Bacillus anthracis, Mycobacterium tuberculosis, Clostridium botulinum, Clostridium tetani, and Streptococcus.
- Next, an example of a method of producing the antimicrobial/antiviral composition according to this embodiment will be specifically described.
- First, a resin, which is a main ingredient of the above-described antimicrobial/antiviral composition, is mixed with a hydrophilic compound. For the mixing procedure, it is possible to use a mixer, a homogenizer, a bead mill, a ball mill, a three-roll mill, or another instrument. Depending on the purpose, the antimicrobial/antiviral composition of this embodiment may be optionally blended with an additional additive(s) (e.g., a flame retardant, a flame retardant aid, a stabilizer, a UV absorber, a plasticizer, and/or a lubricant), a pigment, a filler, and/or another ingredient.
- Next, the copper compound microparticles used in this embodiment are ground to particles in nano-order by using, for instance, a jet mill, a hammer mill, a ball mill, a vibration mill, or a bead mill. The grinding procedure is not particularly limited and both dry and wet processes may be utilized. At this time, an inorganic compound for coating the copper compound microparticles is added. After the inorganic compound is added, the copper compound microparticles and the inorganic compound are in contact with each other and are crushed. Then, the inorganic compound with a smaller particle size occurs. At the same time, electrostatic attraction causes the inorganic compound to be attached to the surface of each copper compound microparticle. Then, an antimicrobial/antiviral agent is obtained in which the copper compound microparticles are coated with the inorganic compound. This antimicrobial/antiviral agent and a mixture of a resin and a hydrophilic compound are mixed to yield an antimicrobial/antiviral composition.
- The procedure for coating the surface of each copper compound microparticle with a metal hydroxide, a metal oxide, or a metal peroxide as the inorganic compound may include: dispersing copper compound microparticles in an aqueous solution containing such a dissolved metal compound so as to chemically adsorb the metal compound on the surface of each copper compound microparticle; or dispersing copper compound microparticles in a solvent containing a dispersed metal compound so as to precipitate the metal compound on the surface of each copper compound microparticle.
- Examples of another procedure include a mechanochemical procedure. This procedure is a process for embedding child particles into mother particles by applying strong pressure to core mother particles (in this embodiment, copper compound microparticles) and child particles (in this embodiment, an inorganic compound) covering the mother particles by using a rolling ball mill, a high-speed rotary grinder, a high-speed flow impact grinder, a medium-agitating mill, or a mechanical fusion device. When this procedure is used, it is preferable that the copper compound microparticles, which are mother particles, should be beforehand ground to a desired particle size by the above process.
- Examples of an apparatus allowing for preparation of the mother particles and the child particles include: a rotary blade type such as a super mixer from KAWATA MFG. CO., LTD.; and a shaker type such as a paint shaker from ASADA IRON WORKS. CO., LTD., a Hybridization System (registered trademark) manufactured by NARA MACHINERY CO., LTD., a Mechanofusion (registered trademark) from Hosokawa Micron Group, or a medium flow dryer. However, the apparatus is not particularly limited to these devices. The devices allowing for both grinding and coating of child particles may be used, including an automated mortar, a high-speed rotary grinder, a high-speed flow impact grinder, or a rolling ball mill. In this case, it is unnecessary to beforehand crush copper compound microparticles which are mother particles.
- Next, an antimicrobial/antiviral coating using the antimicrobial/antiviral composition of this embodiment will be described in detail.
- The antimicrobial/antiviral coating of an embodiment of the invention includes the above-mentioned antimicrobial/antiviral composition. Then, the antimicrobial/antiviral coating of this embodiment is characterized in that in a dried and/or cured state (i.e., in a coating film state), the contribution (hereinafter, referred to as polar contribution Rγp) of polar component γsp to surface free energy γs is 2.0% or higher and 40.0% or lower.
- Now, the polar contribution Rγp of coating film when the antimicrobial/antiviral coating of this embodiment is in a dried and/or cured state will be illustrated.
- The surface free energy γs refers to surplus energy of a molecule (or an atom) present on a solid surface or liquid surface when compared to that of a molecule (or an atom) present inside the solid or liquid. The surface free energy γs is defined by the following Formula (1); and the polar contribution Rγp is defined by the following Formula (2). In the following Formula (1), γsp is the polar component in the surface free energy γs and γsd is the non-polar component in the surface free energy γs. In addition, the surface free energy γs, the non-polar component γsd, and the polar component γsp are values when the antimicrobial/antiviral coating of this embodiment is in a dried and/or cured state.
-
- When the surface free energy γs is measured, a surface of coating film, which is subject to measurement, in a dried and/or cured state is coated with a measurement liquid (each of water or diiodomethane is used) to measure the contact angle (θ) of each measurement liquid. The value obtained for the contact angle and the following Formula (3) are used to calculate the polar component γsp and the non-polar component γsd.
-
- θ: Contact angle of measurement liquid on a surface of coating film in a dried and/or cured state
γL: Surface tension of measurement liquid (water or diiodomethane)
γLd: Non-polar component of surface free energy of measurement liquid (water or diiodomethane)
γLp: Polar component of surface free energy of measurement liquid (water or diiodomethane)
γsd: Non-polar component of surface free energy of coating film in a dried and/or cured state
γsp: Polar component of surface free energy of coating film in a dried and/or cured state - Regarding the two measurement liquids (water and diiodomethane), the surface tension γL, the non-polar component γLd, and the polar component γLp may be measured beforehand. When simultaneous equations, in which the contact angles 8 of the two measurement liquids are each assigned in the above Formula (3), are solved, the polar component γsp and the non-polar component γsd can be calculated. When the resulting non-polar component γsd and polar component γsp are assigned to the above Formula (1), the surface free energy γs can be calculated. Then, this surface free energy γs and the polar component γsp may be assigned to the above Formula (2) to calculate the polar contribution Rγp.
- The surface free energy γs may be comparable. Even in this case, as the polar contribution Rγp increases, the antimicrobial/antiviral effect becomes higher. The rationale is not necessarily clear at the moment. However, it seems that as the polar contribution Rγp increases, microbial cells and/or viruses attached to the coating film surface spread more readily. This causes the antimicrobial/antiviral agent to easily contact the microbial cells and the viruses, thereby enhancing the antimicrobial/antiviral effect.
- In addition, a material to be coated with the antimicrobial/antiviral coating of this embodiment may have a high intrinsic polar contribution Rγp. Even in this case, the antimicrobial/antiviral effect is not increased unless the hydrophilic compound is included. The rationale is unclear, but it seems that if the hydrophilic compound is not included, microbial cells and viruses are unlikely to spread on the coating film surface and are thus not readily in contact with the antimicrobial/antiviral agent.
- The polar contribution Rγp of coating film in a dried and/or cured state may be adjusted by how much the hydrophilic compound is added. In order to increase the antimicrobial effect and the antiviral effect, it is preferable that the polar contribution Rγp of a coating film is 2.0% or higher and 40.0% or lower. More preferably, the polar contribution Rγp is 5% or higher and 30% or lower.
- When the polar contribution Rγp is less than 2.0%, the antimicrobial effect and the antiviral effect are insufficient compared to the case where the polar contribution Rγp is 2.0% or higher. To improve the antimicrobial effect and the antiviral effect, it is more preferable that the polar contribution Rγp is 5% or higher. Meanwhile, when the polar contribution Rγp exceeds 40%, the antimicrobial effect and the antiviral effect are not much elevated compared to the case where the polar contribution Rγp is 40% or lower. Because of the above, it is preferable that the polar contribution Rγp is 40% or lower.
- Note that the dried state of an antimicrobial/antiviral coating herein means a state in which when the antimicrobial/antiviral coating is subjected to drying treatment and so on, the antimicrobial/antiviral coating residual content is substantially in a solid state. In addition, the cured state of an antimicrobial/antiviral coating means a state in which when the antimicrobial/antiviral coating is coated/dried, etc., to form a coating film, dust, etc., may be attached to the surface thereof; and even in this case, the dust, etc., is not incorporated into the coating film. The attached dust, etc., may be easily removed by blowing the air. Further, the cured state of an antimicrobial/antiviral coating herein indicates a state of at least a surface of a coating film and does not necessarily means that the inside of the coating film is completely cured.
- Meanwhile, a user can optionally select a resin as a base of the antimicrobial/antiviral coating of this embodiment if the resin is immiscible with the above-mentioned hydrophilic compound. Specific examples used include thermoplastic resins, thermosetting resins, and radiation curable resins that can be cured by irradiation with an electron beam and/or UV light, etc. These resins may be in combination of two or more kinds.
- Examples of the thermoplastic resins include: olefin-based resins such as polyethylene, polypropylene, chlorinated polyethylene; polystyrene resin, polyvinyl acetate resin, polyurethane resin, polyester resin; copolymers containing acrylic acid, acrylic acid ester, methacrylic acid, or methacrylic acid ester as a backbone; acrylic styrene resin, fluorine-based resin; cellulose-based resins such as nitrocellulose and ethyl cellulose; drying oil such as castor oil, linseed oil, or Tung oil; and natural resins such as shellac and copal. In addition, examples of the thermosetting resins include phenol resin, epoxy resin, melamine resin, urea resin, unsaturated polyester resin, acrylic silicone resin, alkyd resin, polyurethane resin, thermosetting acrylic resin, and thermosetting polyimide resin.
- Further, the radiation (e.g., an electron beam or UV light) curable resins are monomers, oligomers, or polymers. From the viewpoints of being capable of increasing the post-cure crosslink density, enhancing the effect of improving the surface hardness, and enhancing the effect of improving the transparency, preferable examples include multifunctional (meth)acrylate compounds such as multifunctional (meth)acrylate monomers, multifunctional (meth)acrylate oligomers, or multifunctional (meth)acrylate polymers. In addition, a photopolymerization initiator may be added depending on the needs. Examples of the photopolymerization initiator include anthraquinone, acetophenone, isopropyl benzoin ether, isobutyl benzoin ether, ethylanthraquinone, carbazole, xanthone, 4-chlorobenzophenone, o-benzoyl methylbenzoate, 2,4-diethylthioxantone, 2-chlorothioxanthone, 2,2-dimethoxy-1,2-diphenylethan-1-one, p-dimethylamino benzoic acid isoamyl ester, p-dimethylamino benzoic acid ethyl ester, 2,2-dimethoxy-2-phenylacetophenone, 1-hydroxycyclohexyl phenyl ketone, 2-hydroxy-2-methyl-1-phenyl-propane-1-one, 1-hydroxycyclohexyl phenyl ketone, 2-benzyl-2-dimethylamino-1(4-morpholinophenyl)-butanone-1, bis(2,4,6-trimethylbenzoyl)-phenylphosphine oxide, methylbenzyl formate, fluorenone, benzophenone, benzaldehyde, fluorene, triphenylamine, Michler's ketone, 3-methylacetophenone, 2-methyl-1-1[4-(methylthio)phenyl]-2-morpholino-propane-1-one, 2,4,6-trimethylbenzoyl diphenylphosphine oxide, and bis-(2,6-dimethylbenzoyl)2,4,4-trimethylpentylphosphine oxide.
- The antimicrobial/antiviral coating of this embodiment may be used to coat each different target member to give the antimicrobial/antiviral performance.
- Examples of the target member include fiber structures, films, and sheets. Examples of the fiber structures capable of having a coating film include woven fabrics and nonwoven fabrics. Specific application examples of them include masks, filters for air conditioners, filters for air cleaners, filters for vacuum cleaners, filters for ventilators, vehicle filters, air conditioning filters, clothing, protective clothing, bedding, window screen nets, and henhouse nets. Each fiber structure may include a polymer material (e.g., polyester, polyethylene, polypropylene, polyvinyl chloride, polyethylene terephthalate, polybutylene terephthalate, polytetramethylene terephthalate, nylon, acryl, polytetrafluoroethylene, polyvinyl alcohol, Kevlar, polyacrylic acid, polymethyl methacrylate, rayon, Cupra, Tencel, polynosic, acetate, triacetate, cotton, hemp, wool, silk, bamboo) and/or fiber containing a metal (e.g., aluminum, iron, stainless steel, brass, copper, tungsten, titanium).
- Examples of materials for the films include those containing a resin such as polyester, polyethylene, polypropylene, polyamide, polyvinyl chloride, polyvinylidene fluoride, polyvinyl alcohol, polyvinyl acetate, polyimide, polyamide imide, polytetrafluoroethylene, or an ethylene tetrafluoride-ethylene copolymer.
- Examples of the sheets include polymer-made sheets (e.g., polycarbonate resin sheets, film vinyl chloride sheets, fluorine resin sheets, polyethylene sheets, silicone resin sheets, nylon sheets, ABS sheets, urethane sheets) or sheets containing a metal (e.g., titanium, aluminum, stainless steel, magnesium, brass).
- Specific application examples of the films and/or sheets include wallpapers and windows, ceilings, vehicle seats, doors, window shades, chairs, sofas, floor materials, facilities in which microbial cells and/or viruses are involved, train/vehicle interior materials, interior materials for buildings such as hospitals, agricultural materials, or roller shutters. They are applicable to various fields.
- Further, the antimicrobial/antiviral coating of this embodiment may be directly applied to a panel, a construction decorative material, an interior material, a writing instrument, a handrail, a strap, a phone, a toy, or a molding such as a door handle to form a film (coating film). Examples of the polymer-made molding include moldings formed by using ABS, polycarbonate, nylon, polypropylene, polystyrene, polyacetal, polyester, or the like. In addition, examples of the metal molding include moldings formed by using aluminum, zinc, magnesium, brass, stainless steel, titanium, or the like. The surface of the metal molding may have a metal thin film, a coating, or a printing, etc., prefabricated by electroplating or electroless plating.
- Next, an example of a method of producing the antimicrobial/antiviral coating according to this embodiment will be specifically described.
- Like the method of producing the above-described antimicrobial/antiviral composition, a mixture obtained by mixing a resin and a hydrophilic compound and a ground antimicrobial/antiviral agent (copper compound microparticles coated by a dispersant) are prepared. Then, they are mixed to yield an antimicrobial/antiviral coating of this embodiment. Depending on the purpose, the antimicrobial/antiviral coating may be optionally blended with an additional additive(s) (e.g., a flame retardant, a flame retardant aid, a stabilizer, a UV absorber, a plasticizer, and/or a lubricant), a pigment, a filler, and/or another ingredient.
- The following details an antimicrobial/antiviral resin member using the antimicrobial/antiviral composition of the above embodiment.
- The antimicrobial/antiviral resin member according to an embodiment of the invention includes the above-mentioned antimicrobial/antiviral composition. Then, the antimicrobial/antiviral resin member of this embodiment is characterized in that the contribution (hereinafter, referred to as polar contribution Rγp) of polar component γsp to surface free energy γs of the resin member is 2.0% or higher and 40.0% or lower.
- The polar contribution Rγp of the antimicrobial/antiviral resin member of this embodiment is defined by the above Formulas (1) to (3) as described regarding the above-mentioned antimicrobial/antiviral coating. To obtain the antimicrobial/antiviral resin member, a solvent may be removed and dried by heating and reheating and/or irradiation with infrared light, UV light, an electron beam, a γ ray, or the like may cause curing. Because of this, in the above Formulas (1) and (2), the surface free energy γs, the non-polar component γsd, and the polar component γsp are values when the antimicrobial/antiviral resin member of this embodiment is in a dried and/or cured state. In addition, in the above Formula (3), a surface of the antimicrobial/antiviral resin member is used instead of the coating film surface.
- Like the polar contribution Rγp of coating film of the antimicrobial/antiviral coating, when the polar contribution Rγp is less than 2.0%, the antimicrobial/antiviral effect is insufficient when compared to the case where the polar contribution Rγp is 2.0% or higher. Meanwhile, when the polar contribution Rγp exceeds 40.0%, the antimicrobial/antiviral effect is not much elevated compared to the case where the polar contribution Rγp is 40.0% or lower. Because of the above, it is preferable that the polar contribution Rγp is 40.0% or lower. The polar contribution Rγp of the antimicrobial/antiviral resin member is preferably 5.0% or higher and 30.0% or lower and more preferably 10.0% or higher and 20.0% or lower. To improve the antimicrobial/antiviral effect, the polar contribution Rγp is preferably 5.0% or higher and more preferably 10.0% or higher.
- The content of the hydrophilic compound in the antimicrobial/antiviral resin member of this embodiment is not particularly limited and can be set by those skilled in the art, if appropriate. The content is preferably 0.01 mass % or higher and 50.0 mass % or lower with respect to 100 mass % of the antimicrobial/antiviral resin member. When the content of the hydrophilic compound is less than 0.01 mass %, the polar contribution Rγp of the antimicrobial/antiviral resin member cannot be adequately increased when compared to the case where the content of the hydrophilic compound is 0.01 mass % or higher. In addition, when the content of the hydrophilic compound exceeds 50.0 mass %, the strength of the antimicrobial/antiviral resin member is lower than that of the case where the content of the hydrophilic compound is 50.0 mass % or lower. Further, when the content of the hydrophilic compound is 0.01 mass % or higher and 50.0 mass % or lower and the content of the hydrophilic compound is larger than the content of the antimicrobial/antiviral agent, the strength of the antimicrobial/antiviral resin member may be decreased. Thus, it is preferable that the content of the hydrophilic compound is below the content of the antimicrobial/antiviral agent.
- The base resin for the antimicrobial/antiviral resin member is not particularly limited as long as the resin is immiscible with the above-stated hydrophilic compound. Examples include: thermoplastic resins such as polyester resin, polyethylene resin, polypropylene resin, polystyrene resin, ABS resin, AS resin, EVA resin, polymethylpentene resin, polyvinyl chloride resin, polyvinylidene chloride resin, methyl polyacrylate resin, polyvinyl acetate resin, polyamide resin, polyimide resin, polycarbonate resin, polyethylene terephthalate resin, polytetramethylene terephthalate resin, polybutylene terephthalate resin, polyacetal resin, polyacrylate resin, polysulfone resin, nylon resin, acrylic resin, polyvinylidene fluoride resin, polyethylene tetrafluoroethylene resin, polytetrafluoroethylene resin, polyvinyl alcohol resin, Kevlar (registered trademark), and polymethyl methacrylate resin; silicone resins; styrene-based elastomers such as polystyrene elastomers; olefin-based elastomers such as polyethylene elastomers or polypropylene elastomers; polyurethane-based elastomers such as polyurethane elastomers; thermoplastic elastomers such as vinyl chloride-based elastomers, polyester-based elastomers, or nylon-based elastomers; and rayon, Cupra (registered trademark), Tencel (registered trademark), polynosic, acetate, and triacetate. These resins may be in combination of two or more kinds.
- Regarding the hydrophilic compound in the antimicrobial/antiviral composition when used for the antimicrobial/antiviral resin member of this embodiment, a liquid hydrophilic compound may be used. In this case, foaming, etc., may occur. Thus, it is preferable to use a solid hydrophilic compound.
- Further, the antimicrobial/antiviral resin member of this embodiment may contain the above-stated antimicrobial/antiviral composition. As long as the purpose of the invention of the present application can be achieved, an additional ingredient(s) may be included and the shape thereof is also not limited.
- For instance, the antimicrobial/antiviral resin member of this embodiment may be a molded product and may be shaped like a sheet, a film, fiber, a cloth, a mesh (net structure), a honeycomb, a nonwoven fabric, or the like. When the antimicrobial/antiviral resin member is fibrous, nano-fiber (fiber with an average fiber diameter of 5 nm or larger and less than 1 μm) may be allowed. Note that the average fiber diameter refers to the average of the fiber diameters of plural nano-fibers. The fiber diameter of nano-fiber may be measured, using a microscope, by examining a nano-fiber image. Specifically, multiple nano-fibers are observed with an electron microscope, etc., and some of the nano-fibers are selected at random in the resulting observed image. Then, image processing software is used to measure the fiber diameter of each nano-fiber and the average of the respective fiber diameters can be calculated.
- Next, an example of a method of producing the antimicrobial/antiviral resin member of this embodiment is specifically described.
- A first master batch pellet (first mixture), which is a resin pellet containing the antimicrobial/antiviral agent, is prepared and a second master batch pellet (second mixture), which is obtained by mixing a hydrophilic compound and a base resin pellet at a prescribed weight ratio, is prepared. Next, the first master batch pellet and the second master batch pellet are melted and kneaded. Then, the kneaded material is formed as a predetermined shape to obtain an antimicrobial/antiviral resin member of this embodiment. The first master batch pellet and the second master batch pellet are separately prepared and are then melted and kneaded. This makes it possible to avoid contact between the antimicrobial/antiviral agent and the hydrophilic compound in the antimicrobial/antiviral resin member.
- For instance, the first master batch pellet is prepared as follows. First, ground copper compound microparticles and a dispersant are mixed. After the surface of each copper compound microparticle is coated with the dispersant to produce an antimicrobial/antiviral agent, this antimicrobial/antiviral agent and a resin pellet are mixed. Then, a kneading extruder is used to disperse the antimicrobial/antiviral agent in the resin pellet. Alternatively, ground copper compound microparticles and a dispersant are mixed with a resin pellet. Next, a kneading extruder is used and the dispersant is so attracted to the surrounding of the copper compound microparticles during kneading. As a result, the copper compound microparticles are coated with the dispersant to produce an antimicrobial/antiviral agent. This antimicrobial/antiviral agent is also dispersed in the resin pellet. After the kneaded material is cooled, a pelletizer is used to finely cut the antimicrobial/antiviral agent-containing resin. In this way, the first master batch pellet containing the antimicrobial/antiviral agent is obtained. Note that the proportion (concentration) of the antimicrobial/antiviral agent at the time of manufacture of the first master batch pellet may be set by those skilled in the art, if appropriate.
- For instance, the second master batch pellet is prepared as follows. First, a hydrophilic compound and a resin pellet are mixed at a prescribed weight ratio to yield a mixture. Here, as the resin pellet, the same material as the resin pellet used during manufacture of the first master batch pellet is used. The resulting mixture is melted and kneaded to yield the second master batch pellet.
- A molding machine is used to mold a material obtained by melting and kneading the first and second master batch pellets. Then, it is possible to obtain an antimicrobial/antiviral resin member in which the antimicrobial/antiviral agent and the hydrophilic compound are dispersed in the base resin.
- In addition, when manufactured as a molded product, the antimicrobial/antiviral resin member according to this embodiment can be molded by a process such as injection molding or blow molding.
- Note that examples of the antimicrobial/antiviral resin member according to this embodiment include, in addition to the molded product, a sheet-shaped, a film-shaped, a fiber-shaped, a cloth-shaped, a meshed (net structure), a honeycomb-shaped, or a nonwoven fabric-shaped form, etc. The antimicrobial/antiviral resin member can be manufactured in various forms (e.g., a shape, dimension) fit for their usage. When the antimicrobial/antiviral resin member is manufactured like a sheet or film, a T-die process, an inflation process, or the like may be used for the formation. In addition, when the antimicrobial/antiviral resin member is manufactured like fiber, melt spinning, etc., may be used for the formation. Further, when the antimicrobial/antiviral resin member is manufactured like a nonwoven fabric, it can be manufactured by an existing manufacturing process such as spun-bonding.
- In addition, the antimicrobial/antiviral resin member according to this embodiment may contain, as an additive(s), for instance, a plasticizer, a desiccant, a curing agent, an antiskinning agent, a leveling agent, an anti-sagging agent, an antifungal, a UV absorber, a heat ray absorber, a lubricant, a surfactant, a thickener, a viscosity modifier, a stabilizer, and/or a drying modifier. These additives may be used singly or may be used in combination of two or more kinds. Further, other antiviral composition, antimicrobial composition, antifungal composition, anti-allergen composition, catalyst, antireflection material, and/or material having heat shield characteristics may be added and used.
- The antimicrobial/antiviral resin member of this embodiment is applicable to: fibers; agricultural materials such as house films, tunnel house films; moldings such as trays used in plant factories; panels; construction decorative materials; interior materials; writing instruments; handrails; straps; phones; toys; door handles; stationery such as clear folders or label tapes; sheets; shrinking materials that are contracted when heated; construction decorative materials (e.g., chairs, sofas, exterior wall materials, sashes, doors, window shades, ceiling plates, floor plates, windows); interior materials (e.g., wallpapers, carpets, resin tiles); interior materials for trains or vehicles; clothing; innerwear; socks; gloves; shoe covers; footwear such as shoes; bedding materials (e.g., pajamas, mats, sheets, pillows, pillowcases, blankets, towelkets, futons, futon covers); caps; handkerchiefs; towels; rugs; curtains; filters for air cleaners, air conditioners, ventilators, vacuum cleaners, fans, or the like; various water surface-contacting members (e.g., fishing nets such as fish preserve or fixed nets; filters for water treatment; filters for drinking water; filters for ballast water treatment; in-pipe lining materials; film-shaped members attached, using a bonding agent or adhesive, to surfaces of seashore structures; members bonded, like sheets, to surfaces of ships such as fishing boats or tankers; sheet-shaped members on the inner walls of water intake ports of power plants; pre-filters for water intake ports; inner surfaces of water intake ports; plate coolers; drain pipes; water supply pipes); or fiber structure products (e.g., insect screens, screen printing meshes). Thus, the antimicrobial/antiviral resin member according to this embodiment is a useful member that makes it possible to provide a variety of excellent products in various field.
- An example of a method of producing fiber as the antimicrobial/antiviral resin member will be specifically described.
- A first master batch pellet, which is a resin pellet containing the antimicrobial/antiviral agent, is prepared and a second master batch pellet, which is obtained by mixing a hydrophilic compound and a resin pellet at a prescribed weight ratio, is prepared. Next, the first master batch pellet and the second master batch pellet are mixed, melted, and kneaded to produce a spinning raw material. Then, the resulting spinning raw material may be subjected to a melt spinning step to obtain fiber in this embodiment. The melt spinning process is not limited to a specific process and a known process may be used. The spinning temperature may be optionally selected from a temperature range fit for fiber material if the range is set such that discharge from a spinneret is possible while the resin viscosity is appropriately low, neither resin deterioration nor thermal decomposition occurs, the spinning step is not markedly unstabilized, and fiber with high strength can be obtained by subsequent stretching processing.
- In the melt spinning step, spinning raw material is discharged from a spinneret; the discharged fibrous spinning raw material is cooled and solidified to yield fiber. Specifically, the discharged spinning raw material is cooled to a solidification temperature or lower and solidified in a medium such as the air, water, or glycerol. In the case of water-cooling-type cooling, while heated to about 60° C. and then gradually cooled, fiber does not move at the time of injection into a water tank and can then pass through the water tank. Thus, stability during the cooling is excellent. In the case of air-cooling, the air temperature and the wind speed may be arbitrarily set. However, to suppress the molecular orientation, it is desirable that the wind speed should be low and the temperature is not too low. If the degree of molecular orientation at the cooling time point is high, fiber is not readily stretched when a heating/stretching step is carried out as the next step. Consequently, the antimicrobial/antiviral effect may be unlikely to be obtained.
- Then, the solidified fiber is wound. The winding rate may be set to a given rate. In this regard, however, when the winding rate is lower than the free-fall rate of molten unstretched yarn, uniform unstretched yarn is not necessarily obtained, leading to a decrease in stretchability. Note that when a heating/stretching step is carried out as the next step, the solidified yarn is not necessarily wound and may be subjected, as it is, to the heating/stretching step.
- Next, the heating/stretching step is described. The heating/stretching step is a step of heating and stretching fiber (unstretched yarn) wound in the spinning step. The heating/stretching step may include multiple stretching steps. When the heating/stretching step includes multiple stretching steps, the stretch factors in the respective stretching steps are multiplied to give a total stretch factor. Note that when the heating/stretching step includes a single stretching step, the stretch factor in this single stretching step is a total stretch factor.
- The fiber in this embodiment may be heated and stretched to express much better antimicrobial/antiviral performance and thus can efficiently inactivate bacteria and/or viruses attached to the fiber surface, etc. When the fiber is a monofilament, in particular, the heating and stretching can cause the antimicrobial/antiviral effect to increase. The mechanism of markedly increasing the antimicrobial/antiviral effect by heating and stretching is not necessarily clear at the moment. However, the following rationale may be considered. A surface layer portion of fiber in a molten state during the spinning step is directly cooled and solidified once the cooling begins. Then, the antimicrobial/antiviral agent, which is present in a portion (inner layer portion) inside of the fiber relative to the surface layer portion, is structured such that the agent is not readily in contact with water content outside the fiber. In contrast, the inner layer portion is cooled via the surface layer portion and solidified. Accordingly, the cooling speed of the inner layer portion is lower than the cooling speed of the surface layer portion. This may cause the fiber structure of the surface layer portion to be different from the fiber structure of the inner layer portion. When heating and stretching are carried out under such a state, the stretching is conducted under a heating condition at a glass transition point or higher. This causes the fiber structure of the surface layer portion to be a fiber structure in which the antimicrobial/antiviral agent and water content outside the fiber easily come into contact. On top of that, the heating and stretching make the fiber structure of the surface layer portion close to the fiber structure of the inner layer portion. This seems to impart some effect on the surface charges and/or DNA of bacteria and/or viruses, thereby inactivating them.
- The stretching process is not particularly limited and a known stretching process such as hot roll drawing, hot plate drawing, tubular stretching, stretch-blowing, or laser stretching may be optionally adopted. When hot roll drawing is used for the heating and stretching, the rotational speeds of hot rolls, which are combined in multiple stages, are changed. Accordingly, unstretched yarn can be stretched at a high factor.
- The stretch factor may be optionally selected depending on the fineness of material to be stretched, and the total stretch factor is set usually to 3.0 or higher and 7.0 or less and preferably 4.0 or higher and 6.0 or less. When the stretch factor is 3.0 or higher and 7.0 or less, the molecule is more oriented to give stronger fiber. When the stretch factor is less than 3.0, the antimicrobial/antiviral effect is lower than that in the case of the stretch factor of 3.0 or higher and the resulting fiber strength is lowered. In addition, when the stretch factor exceeds 7.0, the stretching tension becomes extremely high. This may frequently cause yarn rapture, leading to a decrease in yarn productivity.
- Not that the fiber in the antimicrobial/antiviral resin member according to this embodiment may have a core-sheath structure. In this case, the core, for instance, may be formed using a regular resin (antimicrobial/antiviral agent-free resin) and the sheath may be formed using a resin containing the antimicrobial/antiviral agent and/or a hydrophilic compound. This not only can improve the fiber strength, but also provides an advantage such that the content of the antimicrobial/antiviral agent may be decreased. A resin for the core and a resin for the sheath may be the same or different resins.
- The shape of cross-section perpendicular to the longitudinal direction of the fiber in the core-sheath structure is not particularly limited, and the cross-sectional shape is preferably circular and the core and the sheath are preferably shaped like concentric circles. The ratio of the area of the core to the area of the sheath in the cross-section perpendicular to the longitudinal direction of the fiber is not particularly limited and may be set by a user, if appropriate.
- In addition, the fiber in the antimicrobial/antiviral resin member according to this embodiment may contain, as an additive(s), for instance, a plasticizer, a desiccant, a curing agent, an antiskinning agent, a leveling agent, an anti-sagging agent, an antifungal, a UV absorber, a heat ray absorber, a lubricant, a surfactant, a thickener, a viscosity modifier, a stabilizer, and/or a drying modifier. These additives may be used singly or may be used in combination of two or more kinds. Further, other antiviral composition, antimicrobial composition, antifungal composition, anti-allergen composition, catalyst, antireflection material, and/or material having heat shield characteristics may be added and used.
- The fiber in the antimicrobial/antiviral resin member according to this embodiment may be used for woven fabrics, knitted fabrics, nonwoven fabrics, paper materials such as mixed papers, and so on. Then, this fiber can be used for various products including: sheet-shaped products (e.g., clothing, bedding, bedding materials, masks, handkerchiefs, towels, rugs, curtains, exterior wall materials, construction decorative materials, interior materials); filters for air cleaners, air conditioners, ventilators, vacuum cleaners, fans, air-conditioning, or vehicles; fishing nets such as fish preserve or fixed nets; filters for water treatment; filters for drinking water; filters for ballast water treatment; protective clothing; protection nets; insect screens; or henhouse nets. The fiber in this embodiment is therefore a useful material that makes it possible to provide a variety of excellent products in various fields.
- Hereinafter, the invention is specifically described by referring to Examples. However, the invention is not restricted to just these Examples.
- First, 40.0 g of commercially available copper iodide (I) powder (manufactured by Wako Pure Chemical Corporation), which is monovalent copper compound microparticles, and 60.0 g of zirconium oxide particles (manufactured by NIHON DENKO, Inc.), which are inorganic compound microparticles, were pre-dispersed in 900.0 g of methanol. Next, the mixture was crushed and dispersed with a bead mill to prepare a slurry of copper iodide particles coated with zirconium oxide having an average particle size of 140 nm. Note that the average particle size herein refers to a volume-average particle size.
- Then, polyvinylpyrrolidone (PVP) and an olefin-based resin were provided and mixed in a toluene solvent. After the mixture was dispersed using a ball mill, the above-described copper iodide particles coated with zirconium oxide were added and further dispersed to produce an antimicrobial/antiviral coating. In Examples 1 to 3, the mass % of each raw material included in the antimicrobial/antiviral coating is as designated in the following Table 1.
- Each resulting antimicrobial/antiviral coating was applied onto a polypropylene sheet (with a thickness of 200 μm) by using a bar coater (#20) and then dried to obtain a sheet painted with the antimicrobial/antiviral coating. At that time, the thickness of the coating film was 2 μm.
- A sheet painted with an antimicrobial/antiviral coating was obtained under the same conditions as for Example 1 except that polyethylene glycol (PEG) was used instead of polyvinylpyrrolidone. The mass % of each raw material included in the antimicrobial/antiviral coating was as designated in the following Table 1.
- A sheet painted with an antimicrobial/antiviral coating was obtained under the same conditions as for Example 1 except that a urethane-based resin was used instead of the olefin-based resin. The mass % of each raw material included in the antimicrobial/antiviral coating was as designated in the following Table 1.
- A sheet painted with an antimicrobial/antiviral coating was obtained under the same conditions as for Example 5 except that polyethylene glycol was used instead of polyvinylpyrrolidone. The mass % of each raw material included in the antimicrobial/antiviral coating was as designated in the following Table 1.
- A sheet painted with an antimicrobial/antiviral coating was obtained under the same conditions as for Example 1 except that an acryl-based resin was used instead of the olefin-based resin. The mass % of each raw material included in the antimicrobial/antiviral coating was as designated in the following Table 1.
- First, 40.0 g of commercially available cuprous oxide powder (manufactured by Wako Pure Chemical Corporation), which is monovalent copper compound microparticles, and 60.0 g of zirconium oxide particles (manufactured by NIHON DENKO, Inc.), which are inorganic compound microparticles, were pre-dispersed in 900.0 g of methanol. Next, the mixture was crushed and dispersed with a bead mill to prepare a slurry of cuprous oxide particles coated with zirconium oxide having an average particle size of 140 nm. Note that the average particle size herein refers to a volume-average particle size.
- Then, polyvinylpyrrolidone and an olefin-based resin were provided and mixed in a toluene solvent. After the mixture was dispersed using a ball mill, the above-described cuprous oxide particles coated with zirconium oxide were added and further dispersed to produce an antimicrobial/antiviral coating. The mass % of each raw material included in the antimicrobial/antiviral coating was as designated in the following Table 1.
- The resulting antimicrobial/antiviral coating was applied onto a polypropylene sheet (with a thickness of 200 μm) by using a bar coater (#20) and then dried to obtain a sheet painted with the antimicrobial/antiviral coating. At that time, the thickness of the coating film was 2 μm.
- A sheet painted with an antimicrobial/antiviral coating was obtained under the same conditions as for Example 8 except that a urethane-based resin was used instead of the olefin-based resin. The mass % of each raw material included in the antimicrobial/antiviral coating was as designated in the following Table 1.
- A sheet painted with an antimicrobial/antiviral coating was obtained under the same conditions as for Example 8 except that an acryl-based resin was used instead of the olefin-based resin and polyethylene glycol was used instead of polyvinylpyrrolidone. The mass % of each raw material included in the antimicrobial/antiviral coating was as designated in the following Table 1.
- A just olefin-based resin was a material, mixed in a toluene solvent, and dispersed with a ball mill to produce a coating. The mass % of the olefin-based resin is 100 mass % as designated in the following Table 2.
- The resulting coating was applied onto a polypropylene sheet (with a thickness of 200 μm) by using a bar coater (#20) and then dried to obtain a sheet painted with the coating. At that time, the thickness of the coating film was 2 μm.
- A sheet painted with a coating was obtained under the same conditions as for Example 1 except that the mixing and dispersion were carried out while copper iodide particles coated with zirconium oxide were not included. The mass % of each raw material included in this coating was as designated in the following Table 2.
- A sheet painted with a coating was obtained under the same conditions as for Example 1 except that the mixing and dispersion were carried out while polyvinylpyrrolidone was not included. The mass % of each raw material included in this coating was as designated in the following Table 2.
- A sheet painted with a coating was obtained under the same conditions as for Example 5 except that the mixing and dispersion were carried out while copper iodide particles coated with zirconium oxide were not included. The mass % of each raw material included in this coating was as designated in the following Table 2.
- A sheet painted with a coating was obtained under the same conditions as for Example 5 except that the mixing and dispersion were carried out while polyvinylpyrrolidone was not included. The mass % of each raw material included in this coating was as designated in the following Table 2.
- A sheet painted with a coating was obtained under the same conditions as for Example 10 except that the mixing and dispersion were carried out while cuprous oxide coated with zirconium oxide were not included. The mass % of each raw material included in this coating was as designated in the following Table 2.
- A sheet painted with a coating was obtained under the same conditions as for Example 10 except that the mixing and dispersion were carried out while polyethylene glycol was not included. The mass % of each raw material included in this coating was as designated in the following Table 2.
- Here, the following Tables 1 and 2 list the respective components of the antimicrobial/antiviral coatings of Examples 1 to 10 and Comparative Examples 1 to 7 described.
-
TABLE 1 Hydrophilic Resin Compound Monovalent Copper Compound Kind Mass % Kind Mass % Kind Mass % Example 1 Olefin 98 PVP 1 Copper Iodide* 1 Example 2 Olefin 96 PVP 1 Copper Iodide* 3 Example 3 Olefin 89 PVP 10 Copper Iodide* 1 Example 4 Olefin 90 PEG 5 Copper Iodide* 5 Example 5 Urethane 94 PVP 3 Copper Iodide* 3 Example 6 Urethane 92 PEG 5 Copper Iodide* 3 Example 7 Acrylic 92 PVP 5 Copper Iodide* 3 Example 8 Olefin 92 PVP 5 Cuprous Oxide* 3 Example 9 Urethane 92 PVP 3 Cuprous Oxide* 5 Example 10 Acrylic 85 PEG 5 Cuprous Oxide* 10 *Dispersant in Examples 1 to 10: Zirconium Oxide -
TABLE 2 Hydrophilic Monovalent Copper Resin Compound Compound Kind Mass % Kind Mass % Kind Mass % Comparative Olefin 100 — — — — Example 1 Comparative Olefin 90 PVP 10 — — Example 2 Comparative Olefin 95 — — Copper 5 Example 3 Iodide* Comparative Urethane 95 PVP 5 — — Example 4 Comparative Urethane 95 — — Copper 5 Example 5 Iodide* Comparative Acrylic 95 PEG 5 — — Example 6 Comparative Acrylic 90 — — Cuprous 10 Example 7 Oxide* *Dispersant in Examples 3, 5, and 7: Zirconium Oxide - (Antiviral Performance Evaluation Protocol)
- When virus inactivation performance of each sheet painted with an antimicrobial/antiviral coating was measured, influenza virus (influenza A/Kitakyushu/159/93(H3N2)) cultured using MDCK cells was used.
- Each sheet (50 mm×50 mm) painted with the antimicrobial/antiviral coating of each one of Examples 1 to 10 and Comparative Examples 1 to 7 was placed on a plastic dish. Next, 100 μL of virus liquid diluted with PBS was added dropwise thereto and reacted at 25° C. for 15 min. At that time, an upper surface of the sheet test product was covered with a PET film (40 mm×40 mm) such that the area of contact between the virus liquid and the sheet test product was made constant. Then, testing was conducted. After 10-min reaction, 900 μL of SCDLP broth was added so as to stop the reaction. Then, the virus was purged by pipetting. Subsequently, MEM diluent was used to dilute each post-reaction virus liquid to from 10−1 to 10−5 (10-fold serial dilution) to prepare sample solutions. Then, 100 μL of each sample solution was seeded onto MDCK cells cultured on a dish. The cells seeded with the sample solution were allowed to stand for 60 min in an incubator at 34° C. and 5% CO2. After the virus was adsorbed on the cells, 0.7% agar broth was overlaid and the virus was cultured for 48 h in the incubator at 34° C. and 5% CO2. After the culturing, formalin fixation and methylene blue staining were conducted and the number of plaques formed was counted to calculate a viral infectivity titer (PFU/0.1 mL, Log 10) (PFU: plaque-forming units).
- (Antimicrobial Performance Evaluation Protocol)
- When antimicrobial performance of each sheet painted with an antimicrobial/antiviral coating was measured, E. coli cultured in NB broth was used.
- Each sheet (50 mm×50 mm) painted with the antimicrobial/antiviral coating of each one of Examples 1 to 10 and Comparative Examples 1 to 7 was placed on a plastic dish. Next, 100 μL of microbial cell liquid, which was diluted with 1/500 NB broth until the cell count reached 2.5×105 to 10×106, was added dropwise thereto and reacted at 35° C. for 10 min. At that time, an upper surface of the sheet test product was covered with a PET film (40 mm×40 mm) such that the area of contact between the microbial cell liquid and the sheet test product was made constant. Then, testing was conducted. After 15-min reaction, 4 mL of SCDLP broth was added so as to stop the reaction. Then, the microbial cells were purged by pipetting. Subsequently, SCDLP broth was used to dilute each post-reaction microbial cell liquid to from 10−1 to 10−5 (10-fold serial dilution) to prepare sample solutions. Then, 1 mL of each sample solution was pipetted onto a dish and 1.5% agar broth was added and mixed therewith. The inverted dish was placed in an incubator at 37° C. and the microbial cells were cultured for 24 to 48 h. After that, the number of colonies was counted to calculate the viable cell count of the microbial cells (CFU/0.1 mL, Log 10) (CFU: colony-forming units).
- (Procedure for Measuring Surface Free Energy)
- Each sheet painted with the antimicrobial/antiviral coating of each one of Examples 1 to 10 and Comparative Examples 1 to 7 was used to measure the contact angle of each measurement liquid (water or diiodomethane was used) by using a contact angle meter (a solid/liquid interface analyzer DropMaster300, manufactured by Kyowa Interface Science, Inc.). Each measurement result was used to calculate a polar component γsp and a non-polar component γsd by using the above Formula (3) and to calculate the surface free energy γs of each coating film by using the above Formula (1). In addition, the above Formula (2) was used to calculate a polar contribution Rγp.
- Here, Tables 3 and 4 collectively provide the respective measurement results of the sheets painted with the antimicrobial/antiviral coatings of Examples 1 to 10 and Comparative Examples 1 to 7 described.
-
TABLE 3 Antiviral Antimicrobial Performance Performance Infectivity Viable Cell Surface Free Polar Titer Count Energy Contribution PFU/0.1 mL, CFU/0.1 mL, γs Rγp Log10 Log10 [mJ/m2] [%] Example 1 2.1 1.7 39.5 9.6 Example 2 1.6 1.2 39.0 8.9 Example 3 <1.3 <1.0 39.9 17.6 Example 4 <1.3 <1.0 39.6 12.5 Example 5 <1.3 <1.0 40.4 25.7 Example 6 <1.3 <1.0 40.0 24.5 Example 7 <1.3 <1.0 40.2 26.1 Example 8 2.5 2.4 38.7 17.0 Example 9 2.6 2.8 40.4 24.0 Example 10 <1.3 <1.0 39.4 24.6 Control 5.8 5.6 — — -
TABLE 4 Antiviral Antimicrobial Performance Performance Infectivity Viable Cell Surface Free Polar Titer Count Energy Contribution PFU/0.1 mL, CFU/0.1 mL, γs Rγp Log10 Log10 [mJ/m2] [%] Comparative 5.8 5.7 38.6 5.7 Example 1 Comparative 5.7 5.4 38.8 17.4 Example 2 Comparative 4.4 4.1 38.8 6.0 Example 3 Comparative 5.7 5.7 40.5 26.0 Example 4 Comparative 4.1 4.6 39.2 20.7 Example 5 Comparative 4.3 4.7 40.0 24.3 Example 6 Comparative 4.9 4.1 39.1 22.6 Example 7 Control 5.8 5.6 — — - The above results demonstrated potent antimicrobial/antiviral performance regardless of short sensitized time of 10 min in all the Examples 1 to 10. However, in Comparative Examples 1 to 7, the antimicrobial/antiviral performance was not found. In view of the above, when an antimicrobial/antiviral coating of the invention is used, the antimicrobial/antiviral effects can be easily imparted to various products.
- The coating prepared using the procedure in Example 3 was that in Example 11.
- The coating in Comparative Example 8 was a coating adjusted using the same procedure as in Example 3 except that zirconium oxide particles (manufactured by NIHON DENKO, Inc.), which are inorganic compound microparticles, were not used, that is, copper iodide particles not coated with zirconium oxide particles were used.
- (Storage Stability Assessment)
- An accelerated test was carried out such that the samples of Example 11 and Comparative Example 8 were left for 3 months under conditions at a temperature of 50° C. and a humidity of 90%. Then, a color change (color difference ΔE) between before and after the test was determined with a color-difference meter. Table 5 shows the results.
-
TABLE 5 Color Difference (ΔE) Example 11 0.8 Comparative Example 8 5.3 - The results of Table 5 demonstrated that the coating of Comparative Example 8, in which copper iodide not coated with zirconium oxide was used, had a larger color change than that of Example 11, in which copper iodide coated with zirconium oxide was used. It is postulated that a change from a monovalent copper compound to a divalent copper compound was suppressed by coating the surface of copper iodide with zirconium oxide.
- (Antimicrobial/Antiviral Performance Evaluation Protocol)
- Each coating of Example 11 or Comparative Example 8 was applied onto a polypropylene sheet and dried in the same procedure as in Example 3. The antimicrobial/antiviral performance of each resulting sheet was evaluated by the above-described evaluation protocol. The results are shown in Table 6.
-
TABLE 6 Antiviral Performance Antimicrobial Performance Infectivity Titer Viable Cell Count PFU/0.1 mL, Log10 CFU/0.1 mL, Log10 Example 11 <1.3 <1.0 Comparative 3.4 4.1 Example 8 Control 5.8 5.6 - The results of Table 6 indicate that Comparative Example 8, in which the color change was large, exhibited low effectiveness in both antiviral performance and antimicrobial performance; by contrast, Example 11, in which the color change was small, maintained both antiviral performance and antimicrobial performance.
- A dry grinder Nano Jetmizer NJ-100B (manufactured by Aishin Nano Technologies CO., LTD.) was used to grind commercially available copper (I) iodide powder (manufactured by NIHON KAGAKU SANGYO CO., LTD.) to an average particle size of 150 nm to yield copper iodide particles. The resulting copper iodide particles and a metal soap, which is a dispersant to prevent aggregation of the copper iodide particles, were mixed.
- A polyethylene (PE) resin pellet (manufactured by Asahi Kasei Chemicals Corporation), as a base resin, was added, such that the content of the copper iodide particles mixed with the dispersant was 40 mass % with respect to the whole master batch pellet, to prepare a mixture. The resulting mixture was fed to a twin-screw melt kneader to obtain a first master batch pellet.
- A polyethylene resin pellet (manufactured by Asahi Kasei Chemicals Corporation), as a base resin, was added, such that the content of polyethylene glycol (with a molecular weight of 20,000) was 20 mass % with respect to the whole master batch pellet, to prepare a mixture. The resulting mixture was fed to a twin-screw melt kneader to obtain a second master batch pellet.
- A polyethylene resin pellet, the first master batch pellet, and the second master batch pellet were mixed so as to have 5 mass % of copper iodide and 3 mass % of polyethylene glycol (with a molecular weight of 20,000) with respect to the whole injection-molded member. An injection molding machine was used to perform injection molding, and an injection-molded member, as an antimicrobial/antiviral resin member, was then obtained.
- A polypropylene (PP) resin pellet as a base resin was added, such that the content of the copper iodide particles mixed with the dispersant (metal soap) was 40 mass % with respect to the whole master batch pellet, to prepare a mixture. The resulting mixture was fed to a twin-screw melt kneader to obtain a master batch pellet.
- An injection-molded member as an antimicrobial/antiviral resin member was obtained under the same conditions as for Example 12 except that the polypropylene (PP) resin pellet, the master batch pellet, and polyethylene glycol were mixed so as to have 5 mass % of copper iodide and 5 mass % of polyethylene glycol with respect to the whole injection-molded member.
- An injection-molded member as an antimicrobial/antiviral resin member was obtained under the same conditions as for Example 13 except that polyvinylpyrrolidone (with a molecular weight of 10,000) was used instead of polyethylene glycol used in Example 13.
- An ABS resin pellet as a base resin was added, such that the content of copper iodide particles ground with the dispersant was 30 mass % with respect to the whole master batch pellet, to prepare a mixture. The resulting mixture was fed to a twin-screw melt kneader to obtain a master batch pellet.
- The ABS resin pellet, the master batch pellet, and polyvinylpyrrolidone were mixed so as to have 5 mass % of copper iodide and 3 mass % of polyvinylpyrrolidone (with a molecular weight of 10,000) with respect to the whole injection-molded member. An injection molding machine was used to perform injection molding, and an injection-molded member, as an antimicrobial/antiviral resin member, was then obtained.
- An injection-molded member as an antimicrobial/antiviral resin member was obtained under the same conditions as for Example 15 except that the ABS resin pellet, the master batch pellet, and polyvinylpyrrolidone were mixed so as to have 5 mass % of copper iodide and 5 mass % of polyvinylpyrrolidone (with a molecular weight of 10,000) with respect to the whole injection-molded member.
- The surface of polypropylene (PP) resin pellet was coated, using a Henschel mixer (registered trademark), with a slurry (40 mass %) of copper iodide particles coated with zirconium oxide having an average particle size of 140 nm as used in Example 1. Next, the coated polypropylene resin pellet was fed to a twin-screw melt kneader to yield a first master batch pellet.
- A polypropylene (PP) resin was added, such that the content of polyethylene glycol (with a molecular weight of 20,000) was 20 mass % with respect to the whole master batch pellet, to prepare a mixture. The resulting mixture was fed to a twin-screw melt kneader to obtain a second master batch pellet.
- A polypropylene (PP) resin pellet, the first master batch pellet, and the second master batch pellet were mixed so as to have 5 mass % of copper iodide and 5 mass % of polyethylene glycol (with a molecular weight of 20,000) with respect to the whole injection-molded member. An injection molding machine was used to perform injection molding, and an injection-molded member as an antimicrobial/antiviral resin member was then obtained.
- A just polypropylene resin pellet was a material and an injection molding machine was used to obtain an injection-molded member.
- An injection-molded member was obtained under the same conditions as for Example 13 except that the polypropylene resin pellet and the master batch pellet were mixed such that polyethylene glycol was not include and the content of copper iodide was 5 mass % with respect to the whole injection-molded member.
- An injection-molded member was obtained under the same conditions as for Example 13 except that the polypropylene resin pellet and polyethylene glycol were mixed such that copper iodide and the dispersant (metal soap) were not included and the content of polyethylene glycol was 10 mass % with respect to the whole injection-molded member.
- A just ABS resin pellet was a material and an injection molding machine was used to obtain an injection-molded member.
- An injection-molded member was obtained under the same conditions as for Example 15 except that the ABS resin pellet and the master batch pellet were mixed such that polyvinylpyrrolidone was not include and the content of copper iodide was 5 mass % with respect to the whole injection-molded member.
- An injection-molded member was obtained under the same conditions as for Example 15 except that the ABS resin pellet and polyvinylpyrrolidone were mixed such that copper iodide and the dispersant (metal soap) were not include and the content of polyvinylpyrrolidone was 10 mass % with respect to the whole injection-molded member.
- The following Table 7 lists the components of the injection-molded members of Examples 12 to 17 and Comparative Examples 9 to 14 described.
-
TABLE 7 Monovalent Copper Compound Hydrophilic Compound Resin Kind Mass % Kind Mass % Example 12 PE Copper 5 Polyethylene Glycol 3 Iodide* Example 13 PP Copper 5 Polyethylene Glycol 5 Iodide* Example 14 PP Copper 5 Polyvinylpyrrolidone 5 Iodide* Example 15 ABS Copper 5 Polyvinylpyrrolidone 3 Iodide* Example 16 ABS Copper 5 Polyvinylpyrrolidone 5 Iodide* Example 17 PP Copper 5 Polyethylene Glycol 5 Iodide* Comparative PP — — — — Example 9 Comparative PP Copper 5 — — Example 10 Iodide* Comparative PP — — Polyethylene Glycol 10 Example 11 Comparative ABS — — — — Example 12 Comparative ABS Copper 5 — — Example 13 Iodide* Comparative ABS — — Polyvinylpyrrolidone 10 Example 14 *Dispersant in Examples 12 to 16 and Comparative Examples 10 and 13: Metal Soap *Dispersant in Example 17: Zirconium Oxide - By using a dry grinder Nano Jetmizer (NJ-100B, manufactured by Aishin Nano Technologies CO., LTD.), commercially available copper (I) iodide powder (manufactured by NIHON KAGAKU SANGYO CO., LTD.) was ground to an average particle size of 150 nm to obtain copper iodide particles. The resulting copper iodide particles and a metal soap, which is a dispersant to prevent aggregation of the copper iodide particles, were mixed.
- A polyethylene resin pellet (manufactured by Asahi Kasei Chemicals Corporation) as a base resin was added, such that the content of the resulting copper iodide particles was 40 mass % with respect to the whole master batch pellet, to prepare a mixture. The resulting mixture was fed to a twin-screw melt kneader to obtain a master batch pellet.
- A polyethylene resin pellet, the master batch pellet, and polyethylene glycol were mixed so as to have 5 mass % of copper iodide and 1 mass % of polyethylene glycol (with a molecular weight of 20,000) with respect to the whole sheet-shaped member. A T-die extruder was used to obtain a sheet-shaped member as an antimicrobial/antiviral resin member with a thickness of 100 μm.
- A sheet-shaped member as an antimicrobial/antiviral resin member was obtained under the same conditions as for Example 18 except that the polyethylene resin pellet, the master batch pellet, and polyethylene glycol were mixed so as to have 5 mass % of copper iodide and 5 mass % of polyethylene glycol with respect to the whole sheet-shaped member.
- A polypropylene resin pellet, as a base resin, was added, such that the content of copper iodide particles was 40 mass % with respect to the whole master batch pellet, to prepare a mixture. The resulting mixture was fed to a twin-screw melt kneader to obtain a master batch pellet. An antimicrobial/antiviral sheet-shaped member was obtained under the same conditions as for Example 18 except that the polypropylene resin pellet, the master batch pellet, and polyethylene glycol were mixed so as to have 5 mass % of copper iodide and 5 mass % of polyethylene glycol with respect to the whole sheet-shaped member.
- A just polyethylene resin pellet was a material and a T-die extruder was used to obtain a sheet-shaped member with a thickness of 100 μm.
- A sheet-shaped member was obtained under the same conditions as for Example 18 except that the polyethylene resin pellet and the master batch pellet were mixed such that polyethylene glycol was not include and the content of copper iodide was 5 mass % with respect to the whole sheet-shaped member.
- A sheet-shaped member was obtained under the same conditions as for Example 18 except that the polyethylene resin pellet and polyethylene glycol were mixed such that copper iodide and the dispersant (metal soap) were not included and the content of polyethylene glycol was 5 mass % with respect to the whole sheet-shaped member.
- A sheet-shaped member was obtained under the same conditions as for Example 18 except that the polyethylene resin pellet and polyvinylpyrrolidone were mixed such that copper iodide and the dispersant (metal soap) were not included and the content of polyvinylpyrrolidone instead of polyethylene glycol was 5 mass % with respect to the whole sheet-shaped member.
- The following Table 8 lists the components of the sheet-shaped members of Examples 18 to 20 and Comparative Examples 15 to 18 described.
-
TABLE 8 Monovalent Copper Compound Hydrophilic Compound Resin Kind Mass % Kind Mass % Example 18 PE Copper 5 Polyethylene Glycol 1 Iodide* Example 19 PE Copper 5 Polyethylene Glycol 5 Iodide* Example 20 PP Copper 5 Polyethylene Glycol 5 Iodide* Comparative PE — — — — Example 15 Comparative PE Copper 5 — — Example 16 Iodide* Comparative PE — — Polyethylene Glycol 5 Example 17 Comparative PE — — Polyvinylpyrrolidone 5 Example 18 *Dispersant in Examples 18 to 20 and Comparative Example 16: Metal Soap - (Antiviral Performance Evaluation Protocol)
- When virus inactivation performance of an injection-molded member or a sheet-shaped member was measured, influenza virus (influenza A/Kitakyushu/159/93(H3N2)) cultured using MDCK cells was used as an enveloped virus. As a non-enveloped virus, feline calicivirus, which has been typically and frequently used as a virus alternative for norovirus, was used.
- (Injection-Molded Member and Sheet-Shaped Member)
- Injection-molded members of Examples 12 to 17 and Comparative Examples 9 to 14 or sheet-shaped members (50 mm×50 mm) of Examples 18 to 20 and Comparative Examples 15 to 18 were each placed on a plastic dish. Next, 100 μL of virus liquid diluted with PBS was added dropwise thereto and reacted at 25° C. for 15 min. At that time, an upper surface of the sheet test product was covered with a PET film (40 mm×40 mm) such that the area of contact between the virus liquid and the sheet test product was made constant. Then, testing was conducted. After 15-min reaction, 900 μL of SCDLP broth was added so as to stop the reaction. Then, the virus was purged by pipetting. Subsequently, MEM diluent was used to dilute each post-reaction virus liquid to from 10−1 to 10−5 (10-fold serial dilution) to prepare sample solutions. Then, 100 μL of each sample solution was seeded onto MDCK cells cultured on a dish. The cells seeded with the sample solution were allowed to stand for 60 min in an incubator at 34° C. and 5% CO2. After the virus was adsorbed on the cells, 0.7% agar broth was overlaid and the virus was cultured for 48 h in the incubator at 34° C. and 5% CO2. After the culturing, formalin fixation and methylene blue staining were conducted and the number of plaques formed was counted to calculate a viral infectivity titer (PFU/0.1 mL, Log 10) (PFU: plaque-forming units).
- (Antimicrobial Performance Evaluation Protocol)
- When antimicrobial performance of each injection-molded member or each sheet-shaped member was measured, Staphylococcus aureus cultured in NB broth was used as gram-positive bacteria. As gram-negative bacteria, E. coli cultured in NB broth was used.
- (Injection-Molded Member and Sheet-Shaped Member)
- Injection-molded members of Examples 12 to 17 and Comparative Examples 9 to 14 or sheet-shaped members (50 mm×50 mm) of Examples 18 to 20 and Comparative Examples 15 to 18 were each placed on a plastic dish. Next, 100 μL of microbial cell liquid, which was diluted with 1/500 NB broth until the microbial cell count reached 2.5×105 to 10×106, was added dropwise thereto and reacted at 35° C. for 60 min. At that time, an upper surface of the sheet test product was covered with a PET film (40 mm×40 mm) such that the area of contact between the microbial cell liquid and the sheet test product was made constant. Then, testing was conducted. After 60-min reaction, 4 mL of SCDLP broth was added so as to stop the reaction. Then, the microbial cells were purged by pipetting. Subsequently, SCDLP broth was used to dilute each post-reaction microbial cell liquid to from 10−1 to 10−5 (10-fold serial dilution) to prepare sample solutions. Then, 1 mL of each sample solution was pipetted onto a dish and 1.5% agar broth was added and mixed therewith. The inverted dish was placed in an incubator at 37° C. and the microbial cells were cultured for 24 to 48 h. After that, the number of colonies was counted to calculate the viable cell count of the microbial cells (CFU/0.1 mL, Log 10) (CFU: colony-forming units).
- (Procedure for Measuring Surface Free Energy)
- A contact angle meter (a solid/liquid interface analyzer DropMaster300, manufactured by Kyowa Interface Science, Inc.) was used to measure the contact angle of each measurement liquid (water or diiodomethane was used) on a surface of each one of the injection-molded members of Examples 12 to 17 and Comparative Examples 9 to 14 or the sheet-shaped members of Examples 18 to 20 and Comparative Examples 15 to 18. These measurement results were used to calculate a polar component γsp and a non-polar component γsd by using the above Formula (3) and to calculate the surface free energy γs of each injection-molded member or each sheet-shaped member by using the above Formula (1). In addition, the above Formula (2) was used to calculate a polar contribution Rγp.
- Here, Table 9 collectively provides the measurement results of the antimicrobial/antiviral resin members that are the injection-molded members of Examples 12 to 17 and Comparative Examples 9 to 14 described.
-
TABLE 9 Antiviral Antimicrobial Performance Performance Surface Polar Infectivity Viable Cell Free Contri- Titer Count Energy bution 15-min 60-min γs Rγp Resin sensitized sensitized [mJ/m2] [%] Example 12 PE 1.8 1.8 34.7 9.6 Example 13 PP <1.3 1.2 34.5 13.6 Example 14 PP <1.3 <1.0 34.9 14.6 Example 15 ABS 2.2 1.6 34.8 7.8 Example 16 ABS <1.3 <1.0 34.6 11.8 Example 17 PP 1.5 1.6 34.7 13.3 Comparative PP 5.7 5.4 35.1 7.4 Example 9 Comparative PP 4.8 4.8 35.1 7.4 Example 10 Comparative PP 5.5 5.2 34.4 18.0 Example 11 Comparative ABS 5.7 5.4 34.8 0.0 Example 12 Comparative ABS 4.9 5.0 34.8 0.1 Example 13 Comparative ABS 5.7 5.2 34.4 17.8 Example 14 Control 5.8 5.4 - As can be seen from the results of the injection-molded members in the above Table 9, in Examples 12 to 17 where an antimicrobial/antiviral agent, a hydrophilic compound, and a dispersant were included in a base resin and the polar contribution Rγp was 2.0% or higher, the viral infectivity titer is more significantly lowered and the viable microbial cell count is also more significantly decreased than those of Comparative Examples 9 to 14.
- The following Table 10 collectively provides the measurement results of the antimicrobial/antiviral resin members that are the sheet-shaped members of Examples 18 to 20 and Comparative Examples 15 to 18.
-
TABLE 10 Antiviral Antimicrobial Performance Performance Surface Polar Infectivity Viable Cell Free Contri- Titer Count Energy bution 15-min 60-min γs Rγp Resin sensitized sensitized [mJ/m2] [%] Example 18 PE 1.8 <1.0 34.7 8.6 Example 19 PE <1.3 <1.0 34.7 13.8 Example 20 PE 1.8 <1.0 34.8 8.0 Comparative PE 5.5 5.4 35.0 5.8 Example 15 Comparative PE 4.3 4.6 35.1 5.7 Example 16 Comparative PE 5.6 5.4 34.7 13.5 Example 17 Comparative PE 5.4 5.4 34.7 12.6 Example 18 Control 5.8 5.4 - As can be seen from the results of the sheet-shaped members of the above Table 10, in Examples 18 to 20 where an antimicrobial/antiviral agent (copper compound microparticles coated with a dispersant) and a hydrophilic compound were included in a base resin, the viral infectivity titer is more significantly lowered and the viable microbial cell count is also more significantly decreased than those of Comparative Examples 15 to 18.
- The above has demonstrated that the antimicrobial and/or antiviral effects can be exerted regardless of the kind of base resin. In addition, it has been verified from the above Tables 9 and 10 that the antimicrobial/antiviral resin members of the invention can elicit the antimicrobial and/or antiviral effects regardless of their form.
- By using a dry grinder Nano Jetmizer (NJ-100B, manufactured by Aishin Nano Technologies CO., LTD.), commercially available copper (I) iodide powder (manufactured by NIHON KAGAKU SANGYO CO., LTD.) was ground to an average particle size of 150 nm to obtain copper iodide microparticles. The resulting copper iodide particles and a metal soap, which is a dispersant to prevent aggregation of the copper iodide particles, were mixed.
- A polypropylene resin pellet (manufactured by Asahi Kasei Chemicals Corporation), as a base resin, was added thereto so as to have 40 mass % of the resulting copper iodide. The resulting mixture was fed to a twin-screw melt kneader to obtain a copper iodide master batch pellet.
- Commercially available polyethylene glycol (manufactured by SANYO CHEMICAL, LTD.) was added at a content of 30 mass % to a polypropylene resin pellet (manufactured by Asahi Kasei Chemicals Corporation) as a base resin. The resulting mixture was fed to a twin-screw melt kneader to obtain a polyethylene glycol master batch pellet.
- A polypropylene resin pellet, the copper iodide master batch pellet, and the polyethylene glycol master batch pellet were mixed using a tumbler so as to have 1 mass % of copper iodide and 3 mass % of polyethylene glycol. Next, melt spinning was carried out to obtain monofilament fiber, which was an antimicrobial/antiviral resin member with a fineness of 300 D.
- Regarding a copper iodide master batch pellet and a polyethylene glycol master batch pellet, those prepared in Example 21 were used.
- A polypropylene resin pellet, the copper iodide master batch pellet, and the polyethylene glycol master batch pellet were mixed using a tumbler so as to have 1 mass % of copper iodide and 3 mass % of polyethylene glycol in its sheath. Next, a polypropylene resin pellet was used as its core. Then, melt spinning was carried out to obtain monofilament fiber that had a core-sheath structure and was an antimicrobial/antiviral resin member having a core-sheath area ratio of 7/3 and a fineness of 300 D.
- Regarding a copper iodide master batch pellet, the one prepared in Example 21 was used.
- A polypropylene resin pellet and the copper iodide master batch pellet were mixed using a tumbler so as to have 1 mass % of copper iodide. Next, melt spinning was carried out to obtain monofilament fiber with a fineness of 300 D.
- The following Table 11 lists the components of the fibers of Examples 21 to 22 and Comparative Example 19 described.
-
TABLE 11 Monovalent Copper Compound Hydrophilic Compound Resin Kind Mass % Kind Mass % Example 21 PP Copper 1 Polyethylene 3 Iodide* Glycol Example 22 PP Copper 1 Polyethylene 3 Iodide* Glycol Comparative PP Copper 1 — — Example 19 Iodide* *Dispersant in Examples 21 and 22 and Comparative Example 19: Metal Soap - (Antiviral Performance Evaluation Protocol)
- When virus inactivation performance of monofilament fiber was measured, influenza virus (influenza A/Kitakyushu/159/93(H3N2)) cultured using MDCK cells was used as an enveloped virus. As a non-enveloped virus, feline calicivirus, which has been typically and frequently used as a virus alternative for norovirus, was used.
- Monofilament fiber, which was an antimicrobial/antiviral resin member of each of Example 21 or 22 or Comparative Example 19, was wound around the middle of a glass plate (50 mm×100 mm) as a single layer with a width of 60 mm without any gap. The glass plate, around which the monofilament fiber was wound, was placed in a plastic container. Then, 200 μL of virus liquid diluted with sterile water was added dropwise and was reacted therewith at 25° C. for 15 min. At that time, an upper surface of the monofilament fiber test product was covered with a PET film (40 mm×40 mm) such that the area of contact between the virus liquid and the monofilament fiber test product was made constant. Then, testing was conducted. After 15-min reaction, 20 mL of SCDLP broth was added so as to stop the reaction. Then, the virus was purged by pipetting. Subsequently, MEM diluent was used to dilute each post-reaction virus liquid to from 10−2 to 10−5 (10-fold serial dilution) to prepare sample solutions. Then, 100 μL of each sample solution was seeded onto MDCK cells cultured on a dish. The cells seeded with the sample solution were allowed to stand for 60 min in an incubator at 34° C. and 5% CO2. After the virus was adsorbed on the cells, 0.7% agar broth was overlaid and the virus was cultured for 48 h in the incubator at 34° C. and 5% CO2. After the culturing, formalin fixation and methylene blue staining were conducted and the number of plaques formed was counted to calculate a viral infectivity titer (PFU/0.1 mL, Log 10) (PFU: plaque-forming units).
- (Antimicrobial Performance Evaluation Protocol)
- When antimicrobial performance of each monofilament fiber as an antimicrobial/antiviral resin member was measured, Staphylococcus aureus cultured using NB broth was used as gram-positive bacteria. As gram-negative bacteria, E. coli cultured using NB broth was used.
- Monofilament fiber, which was an antimicrobial/antiviral resin member of each of Example 21 or 22 or Comparative Example 19, was wound around the middle of a glass plate (50 mm×100 mm) as a single layer with a width of 60 mm without any gap. The glass plate, around which the monofilament fiber was wound, was placed in a plastic container. Then, 100 μL of microbial cell liquid diluted with sterile water was added dropwise and was reacted therewith at 35° C. for 15 min. At that time, an upper surface of the monofilament fiber test product was covered with a PET film (40 mm×40 mm) such that the area of contact between the microbial cell liquid and the monofilament fiber test product was made constant. Then, testing was conducted. After 15-min reaction, 20 mL of SCDLP broth was added so as to stop the reaction. Then, the microbial cells were purged by pipetting. Subsequently, SCDLP broth was used to dilute each post-reaction microbial cell liquid to from 10−1 to 10−5 (10-fold serial dilution) to prepare sample solutions. Then, 1 mL of each sample solution was pipetted onto a dish and 1.5% agar broth was added and mixed therewith. The inverted dish was allowed to stand in an incubator at 37° C. and the microbial cells were cultured for 24 to 48 h. After that, the number of colonies was counted to calculate the viable cell count of the microbial cells (CFU/0.1 mL, Log 10) (CFU: colony-forming units).
- (Surface Free Energy)
- A contact angle meter (an automated micro-contact meter MCA-3, manufactured by Kyowa Interface Science, Inc.) was used to measure the contact angle of each measurement liquid (water or diiodomethane was used) on a surface of the monofilament fiber of Example 21 or 22 or Comparative Example 19. These measurement results were used to calculate a polar component γsp and a non-polar component γsd by using the above Formula (3) and to calculate the surface free energy γs of each monofilament fiber by using the above Formula (1). In addition, the above Formula (2) was used to calculate a polar contribution Rγp.
- Here, the following Table 12 collectively provides the measurement results regarding the monofilament fibers of Examples 21 to 22 and Comparative Example 19 described.
-
TABLE 12 Antiviral Antimicrobial Surface Polar Performance Performance Free Contri- Infectivity Titer Viable Cell Count Energy bution (PFU/0.1 mL, (CFU/0.1 mL, γs Rγp Log10) Log10) [mJ/m2] [%] Example 21 <2.3 <1.3 34.5 9.5 Example 22 <2.3 <1.3 34.7 9.6 Comparative 5.7 2.2 35.1 7.4 Example 19 Control 6.2 6.0 — — - It was found that Examples 21 and 22, where a compound with a polar group (polyethylene glycol) was added, elicited potent antimicrobial performance and antiviral performance. In contrast to this result, the result of Comparative Example 19 free of a compound with a polar group was inferior both in antimicrobial performance and antiviral performance. The above results have confirmed that it is possible to provide potent antimicrobial/antiviral products by using monofilament fiber as an antimicrobial/antiviral resin member of the invention.
- In conclusion, it has been demonstrated that any antimicrobial/antiviral composition, which is included in an antimicrobial/antiviral coating and/or an antimicrobial/antiviral resin member, according to the invention elicits antimicrobial and/or antiviral performance.
Claims (16)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017-169865 | 2017-09-04 | ||
JP2017-169874 | 2017-09-04 | ||
JP2017169865 | 2017-09-04 | ||
JP2017169874 | 2017-09-04 | ||
PCT/JP2018/032677 WO2019045110A1 (en) | 2017-09-04 | 2018-09-03 | Antibacterial/antiviral composition |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2018/032677 A-371-Of-International WO2019045110A1 (en) | 2017-09-04 | 2018-09-03 | Antibacterial/antiviral composition |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/501,310 Continuation US20240065273A1 (en) | 2017-09-04 | 2023-11-03 | Antimicrobial/antiviral composition |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200359633A1 true US20200359633A1 (en) | 2020-11-19 |
Family
ID=65527446
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/638,857 Abandoned US20200359633A1 (en) | 2017-09-04 | 2018-09-03 | Antimicrobial/antiviral composition |
US18/501,310 Pending US20240065273A1 (en) | 2017-09-04 | 2023-11-03 | Antimicrobial/antiviral composition |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/501,310 Pending US20240065273A1 (en) | 2017-09-04 | 2023-11-03 | Antimicrobial/antiviral composition |
Country Status (5)
Country | Link |
---|---|
US (2) | US20200359633A1 (en) |
JP (1) | JP7376355B2 (en) |
CN (1) | CN111065272A (en) |
TW (1) | TW201919477A (en) |
WO (1) | WO2019045110A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022204532A1 (en) * | 2021-03-25 | 2022-09-29 | Penn Color, Inc. | Functional metal-containing articles |
US11470892B1 (en) * | 2021-11-18 | 2022-10-18 | King Abdulaziz University | Antimicrobial metal nanoparticle mesh air filter |
WO2023034262A1 (en) * | 2021-09-03 | 2023-03-09 | Corning Incorporated | Formulations for antimicrobial thermoset coatings |
WO2023044022A1 (en) * | 2021-09-16 | 2023-03-23 | Cupron Inc. | Fibers with embedded particles and methods of producing fibers with embedded particles |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020203069A1 (en) * | 2019-04-04 | 2020-10-08 | リケンテクノス株式会社 | Paint for formation of antiviral coating film, coating film, and laminated film |
JP7436973B2 (en) * | 2019-10-11 | 2024-02-22 | 学校法人東京電機大学 | Method for imparting antibacterial or antiviral properties to amorphous carbon-containing sheets, amorphous carbon-containing sheet products, and breathable sheets |
WO2021215488A1 (en) * | 2020-04-24 | 2021-10-28 | Dic株式会社 | Masterbatch, resin composition, molded article, and manufacturing methods thereof |
EP3964553B1 (en) * | 2020-09-03 | 2023-06-07 | SWISS KRONO Tec AG | Method for the preparation of a substrate with an antiviral coating |
JP6830172B1 (en) * | 2020-10-27 | 2021-02-17 | アイカ工業株式会社 | A photocurable antifogging resin composition and a laminate having a cured layer thereof. |
KR102288357B1 (en) * | 2021-02-25 | 2021-08-09 | 박충현 | Antibacterial film manufacturing method |
JP7109827B1 (en) | 2021-11-16 | 2022-08-01 | 株式会社ハニック・ホワイトラボ | antiviral agent |
WO2023190973A1 (en) * | 2022-03-31 | 2023-10-05 | 株式会社Nbcメッシュテック | Antimicrobial/antiviral resin member |
WO2024005082A1 (en) * | 2022-06-30 | 2024-01-04 | 大日本印刷株式会社 | Anti-viral decorative sheet, and anti-viral adhesive processed sheet and anti-viral decorative board each using same |
WO2024029404A1 (en) * | 2022-08-01 | 2024-02-08 | 積水化学工業株式会社 | Antiviral resin material, method for producing antiviral resin molded article, and antiviral resin molded article |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6073520B1 (en) * | 2015-07-31 | 2017-02-01 | Toto株式会社 | Photocatalyst material and method for producing the same |
CN106561712A (en) * | 2016-10-28 | 2017-04-19 | 上海纳米技术及应用国家工程研究中心有限公司 | Core-shell-structured nano-zinc oxide coated nano-copper oxide composite antibacterial agent as well as preparation method and application |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0384066A (en) * | 1989-08-25 | 1991-04-09 | Toray Ind Inc | Resin composition having antibacterial activity and its preparation |
JP2008008138A (en) * | 2006-05-29 | 2008-01-17 | Toray Ind Inc | Floor material and its manufacturing method |
JP2009155461A (en) * | 2007-12-26 | 2009-07-16 | Fujitsu Ltd | Powder paint and electronic equipment casing |
CA2933788C (en) * | 2008-09-03 | 2017-11-28 | Nbc Meshtec, Inc. | Antiviral agent |
JP2012210557A (en) * | 2011-03-30 | 2012-11-01 | Panasonic Corp | Water-repellent photocatalytic composition and water-repellent photocatalytic coating film |
US9155310B2 (en) * | 2011-05-24 | 2015-10-13 | Agienic, Inc. | Antimicrobial compositions for use in products for petroleum extraction, personal care, wound care and other applications |
AU2012258633A1 (en) * | 2011-05-24 | 2013-11-28 | Agienic, Inc. | Compositions and methods for antimicrobial metal nanoparticles |
CA2841051C (en) * | 2011-07-06 | 2019-05-07 | Nbc Meshtec, Inc. | Antiviral resin member |
CN102558939A (en) * | 2011-12-30 | 2012-07-11 | 长沙科星纳米工程技术有限公司 | Method for preparing new nano-cuprous oxide antifouling material by mechanochemical method |
JP5194185B1 (en) * | 2012-06-20 | 2013-05-08 | 株式会社Nbcメッシュテック | Antiviral composition |
JP6040021B2 (en) * | 2012-12-13 | 2016-12-07 | 昭和電工株式会社 | Antibacterial antiviral composition and method for producing the same |
JP5919528B2 (en) * | 2013-02-27 | 2016-05-18 | パナソニックIpマネジメント株式会社 | Cuprous oxide particle dispersion, coating composition and antibacterial / antiviral component |
WO2014141600A1 (en) * | 2013-03-13 | 2014-09-18 | パナソニック株式会社 | Copper complex titanium oxide dispersion liquid, coating material composition, and antibacterial/antiviral member |
JP2015205998A (en) * | 2014-04-22 | 2015-11-19 | パナソニックIpマネジメント株式会社 | Antiviral coating film |
CN107022043B (en) * | 2017-04-07 | 2019-03-29 | 浙江海洋大学 | A kind of preparation method and its usage of cuprous oxide composite material |
-
2018
- 2018-09-03 CN CN201880057235.0A patent/CN111065272A/en active Pending
- 2018-09-03 WO PCT/JP2018/032677 patent/WO2019045110A1/en active Application Filing
- 2018-09-03 JP JP2019539712A patent/JP7376355B2/en active Active
- 2018-09-03 US US16/638,857 patent/US20200359633A1/en not_active Abandoned
- 2018-09-04 TW TW107130989A patent/TW201919477A/en unknown
-
2023
- 2023-11-03 US US18/501,310 patent/US20240065273A1/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6073520B1 (en) * | 2015-07-31 | 2017-02-01 | Toto株式会社 | Photocatalyst material and method for producing the same |
US10744495B2 (en) * | 2015-07-31 | 2020-08-18 | Toto Ltd. | Photocatalyst material and method for producing same |
CN106561712A (en) * | 2016-10-28 | 2017-04-19 | 上海纳米技术及应用国家工程研究中心有限公司 | Core-shell-structured nano-zinc oxide coated nano-copper oxide composite antibacterial agent as well as preparation method and application |
Non-Patent Citations (1)
Title |
---|
Dannong et al. English Translation of Pub. No. CN 106561712; Pub. Date: April 19, 2019). (Year: 2017) * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022204532A1 (en) * | 2021-03-25 | 2022-09-29 | Penn Color, Inc. | Functional metal-containing articles |
WO2023034262A1 (en) * | 2021-09-03 | 2023-03-09 | Corning Incorporated | Formulations for antimicrobial thermoset coatings |
WO2023044022A1 (en) * | 2021-09-16 | 2023-03-23 | Cupron Inc. | Fibers with embedded particles and methods of producing fibers with embedded particles |
US11470892B1 (en) * | 2021-11-18 | 2022-10-18 | King Abdulaziz University | Antimicrobial metal nanoparticle mesh air filter |
Also Published As
Publication number | Publication date |
---|---|
KR20200047666A (en) | 2020-05-07 |
US20240065273A1 (en) | 2024-02-29 |
CN111065272A (en) | 2020-04-24 |
JP7376355B2 (en) | 2023-11-08 |
WO2019045110A1 (en) | 2019-03-07 |
TW201919477A (en) | 2019-06-01 |
JPWO2019045110A1 (en) | 2020-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240065273A1 (en) | Antimicrobial/antiviral composition | |
JP6055765B2 (en) | Antiviral resin material | |
Anitha et al. | Optical, bactericidal and water repellent properties of electrospun nano-composite membranes of cellulose acetate and ZnO | |
JP6119009B2 (en) | Industrial material sheet | |
TWI523923B (en) | Water-based coating agent, anti-mildew agent and antibacterial agent | |
JP7340657B2 (en) | Antibacterial/antiviral vinyl chloride materials | |
JP6832058B2 (en) | Antibacterial member | |
JP6119010B2 (en) | Industrial material sheet | |
JP6063666B2 (en) | Antiviral fiber and method for producing the same | |
JP2013194329A (en) | Method for producing nanocomposite-nanofiber | |
DE102020125921B4 (en) | Mobile device for cleaning and disinfecting room air that can be operated by a temperature difference | |
KR102675836B1 (en) | Antibacterial/antiviral composition | |
JP2019099783A (en) | Antibacterial and antifungal coating material, algae-proof coating material, production method of antibacterial and antifungal member, and production method of algicidal member | |
KR101398089B1 (en) | Antimicrobial dehumidifier | |
KR20090096114A (en) | Air filter consisted polymethylmethacrylate nanofiber polyethylene terephthalate nonwoven fiber and processing method thereof | |
TW202348253A (en) | Antimicrobial/antiviral resin member | |
DE102020125920B4 (en) | Mobile device for cleaning and disinfecting room air that can be operated by a temperature difference | |
WO2023190965A1 (en) | Antibacterial/antiviral resin composition | |
JP6730959B2 (en) | Method for producing antibacterial and antifungal member | |
DE202020105701U1 (en) | Mobile device for cleaning and disinfecting room air | |
He et al. | Constructed Nano-Microcapsule Coating Coated with AgNPs for Enhanced Antibacterial Activity Effectively | |
DE202021000895U1 (en) | Biocide-impregnated, reticulated foams | |
JP2023013113A (en) | antiviral composition | |
EP3978038A1 (en) | Mobile device operable by means of a temperature difference for cleaning and disinfecting room air and test device for same | |
Sombatsompop | Ratchanee Chinkamonthong, Apisit Kositchaiyong and |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NBC MESHTEC INC., JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TAKINO, MASAKO;KURAHASHI, SHINJI;FUJIMORI, YOSHIE;AND OTHERS;SIGNING DATES FROM 20200128 TO 20200205;REEL/FRAME:051810/0975 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |